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CHAPTER 1 
INTRODUCTION 
 Ethanol is a common factor in traumatic injury, including burn injury.  Previous 
studies from our laboratory indicate that ethanol increases both pulmonary and 
gastrointestinal inflammation as well as susceptibility to infection in burn-injured mice; 
however, the mechanisms of these responses are not entirely known.  Moreover, after 
burn injury, bacteria and their products leak out of the intestinal lumen and into the 
bloodstream.  These bacteria can disperse throughout the body leading to pulmonary 
damage, acute lung injury, sepsis, and death.  Ethanol in combination with burn injury 
has been shown to decrease intestinal barrier function greater than either insult alone.  
Long (210 kDa) smooth muscle myosin light chain kinase (MLCK), an enzyme important 
for epithelial tight junction maintenance, has been implicated in barrier alterations after 
burn injury or ethanol exposure alone.  With this knowledge, we hypothesize that the 
combination of binge ethanol exposure and burn injury causes an increase in intestinal 
barrier dysfunction due to inflammation-mediated activation of myosin light chain 
kinase.  To test this hypothesis, three aims are proposed: 1) to determine whether elevated 
myosin light chain kinase activation mediates the intestinal permeability alterations in 
mice receiving binge ethanol and burn injury treatment, 2) if interleukin-6 (IL-6) 
activates myosin light chain kinase and, 3) the signaling mechanism leading to MLCK 
activation after ethanol exposure and burn injury.  Bacterial translocation along with 
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immunofluorescent staining for tight junction protein localization will be performed to 
investigate intestinal barrier function and integrity.  MLCK activation will be determined 
by Western blot analysis.  Inhibition and knock out of MLCK will be employed as well to 
examine the role of this molecule on intestinal permeability after acute ethanol and burn 
injury exposure.  We will investigate MLCK activation and tight junction integrity in IL-
6 knockout mice and wild type mice given an IL-6 neutralizing antibody.  Finally, we 
will examine the signaling mechanism leading to MLCK activation in our model of 
ethanol and burn.  To do this, activation of other mediators of the MLCK pathway, 
including Rho kinase (ROCK), myosin light chain phosphatase (MLCP) and Src kinase, 
will be determined. These studies will help gain an understanding for how even binge 
ethanol in combination with burn injury can result in decreased barrier function that has 
been clinically observed and can result in increased morbidity and mortality.
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CHAPTER 2 
REVIEW OF RELATED LITERATURE 
The intestinal barrier – homeostasis is key 
Enterocytes and junction complexes 
 Intestinal epithelial cells (IECs) form a single layer barrier separating the lumen 
of the intestine from the intestinal tissue, known as the lamina propria. On the luminal 
side of the intestinal barrier lie trillions of bacteria which have colonized the gut and aid 
in digestion of food. Commensal bacteria are not harmful to the host, and their presence 
in the intestine prevents harmful bacteria from colonizing that niche. Besides enterocytes, 
goblet cells, another type of intestinal epithelial cell, produces mucin to form a mucus 
layer to protect the barrier as well (1).  In addition to protection, the intestinal barrier is 
also responsible for absorption of nutrients and some water balance though most of water 
reabsorption takes place in the large intestine. To form the epithelial layer, polarized 
IECs are connected by several types of junction complexes including tight junctions, 
adherens junctions, and desmosomes (Figure 1). The most apical junction is the tight 
junction and represents the first line of defense from luminal pathogens. Tight junctions 
are composed of various proteins including occludin, claudins, and zonula occludens 
proteins (ZOs) (2). Zonula occludens protein 1 (ZO-1) can bind and cross-link actin (3). 
Other ZO isoforms (ZO-2 and ZO-3) are also capable of binding but not cross-linking 
actin. ZO-1 is also known to bind occludin and claudins thus linking them to the actin 
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Figure 1: A variety of junction complexes adheres intestinal epithelial cells together to 
form a barrier. Intestinal epithelial cells are held together by tight junctions, adherens 
junctions, and desmosomes. Tight junctions are the most apical junction and are 
composed of occludin, claudins, and ZOs. These junctions are anchored to the actin 
cytoskeleton. Just basolateral to tight junctions are adherens junctions, which like tight 
junctions are attached to actin. Cadherins, E-cadherin in epithelial layers, are Ca
2+
-
dependent, transmembrane proteins that use α and β-catenins to anchor the complex to 
actin. Finally, desmosomes, composed of desmoplakin, desmoglein, and desmocollin, are 
anchored to keratin and are the most basolateral of the junction complexes. 
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cytoskeleton (4). While ZO-1 acts as a scaffolding and cross-linking protein, it is 
cytoplasmic and does not interact with other cells. Occludin and claudins are  
transmembrane proteins that bind occludin or claudins from neighboring cells thus 
forming a tight junction. As tight junctions are anchored to actin, they are partially under 
cytoskeletal control. Signals that mediate cytoskeletal contraction, such as histamine, 
thrombin, and sodium absorption also cause tight junction disruption and permeability (5-
7). While this permeability is essential for absorption of some nutrients, extensive or 
prolonged openings in the barrier can allow bacteria to move into the intestinal tissue 
causing inflammation and tissue damage. Adherens junctions and desmosomes also 
connect IECs. Adherens junctions are just basolateral to tight junctions and contain 
cadherins, E-cadherin in epithelial barriers, as well as β and α-catenin (8). Cadherins are 
Ca
2+
-dependent, transmembrane proteins and using the catenin proteins, also anchor to 
the actin cytoskeleton (8). Unlike the other more apical junction complexes, desmosomes 
are anchored to keratin. Desmoglein and desmocollin are transmembrane proteins that 
bind to desmoplakin, which then anchors the entire complex to keratin (9).  
Immune component of the intestinal epithelial barrier and lamina propria 
 Besides enterocytes, several other types of cells, such as intestinal epithelial 
lymphocytes (IEL) and specialized epithelial cells compose the intestinal epithelial 
barrier. (Figure 2). These cells fit predominantly into 2 classes, immune cells and other 
types of intestinal epithelial cells. IELs are T cells scattered throughout the epithelial 
barrier and are essential for fighting and killing bacteria and other attacks, such as 
viruses, on the barrier (10). These T cells also produce antimicrobial peptides which 
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Figure 2: The intestinal barrier contains a diverse population of cells. The intestinal epithelial 
barrier consists of many different cell types besides enterocytes. Goblet cells secrete mucin, 
which helps create the protective, mucus barrier. Paneth cells reside in the crypt and contain 
granules containing AMPs and other bacteria-killing compounds. Both goblet and Paneth 
cells prevent bacteria from adhering from the epithelial barrier. M cells reside in the 
epithelial lining of the ileum adjacent to Peyer’s patches. Bacteria translocate through these 
cells into the lamina propria where they are phagocytosed by antigen presenting cells and 
presented to resident lymphocytes for killing or to develop tolerance. IELs are important for 
bacterial killing in cases of infection, but also for maintenance of tolerance to commensal 
bacteria. Finally, dendritic cells can intercalate themselves into the epithelial layer to sample 
the bacterial products in the lumen to generate tolerance. 
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prevents bacterial overgrowth (11). Furthermore, dendritic cells can intercalate into 
intestinal epithelial barrier in order to detect bacterial products and initiate subsequent  
activation of the immune response which involves activation of T cells and cytokine and 
chemokine production recruiting more lymphocytes to fight the insult (12). Dendritic 
cells also randomly sample the luminal bacterial products in order to promote tolerance to 
tolerance of commensal bacterial (12). Without tolerance, a constant immune response to 
the commensal bacteria would happen and lead to malabsorption and tissue damage. In 
addition to dendritic cells in the lamina propria and Peyer’s patches, macrophages reside 
in these areas as well and act as phagocytes and antigen presenting cells as necessary. 
Together, IELs, dendritic cells, and macrophages (as well as lamina propria resident 
lymphocytes and occasional neutrophils) comprise a vast component of the immune 
system in charge of regulating intestinal epithelial immunity and tolerance. 
Specialized intestinal epithelial cells and stem cells 
 Paneth cells, goblet cells, M cells, transit amplifying cells and intestinal stem cells 
constitute the rest of the intestinal barrier. Found only in the crypts, Paneth cells contain 
granules consisting of antimicrobial peptides (AMPs) and other compounds necessary for 
killing bacteria (13). Enterocytes are also capable of producing AMPs to aid in the 
defense of the intestinal epithelial barrier (14). As mentioned previously, goblet cells 
release mucin, the predominant component of the mucus layer. Goblet cells are found 
throughout both crypts and villi to maintain the protective mucus layer (15). Finally, 
microfold (M) cells are specialized epithelial cells found only in the ileum. M cells sit 
directly above Peyer’s patches, organized areas of immune cells necessary for quick 
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response to infection or injury (16). Pathogens may translocate through M cells and 
encounter immune cells within the Peyer’s patch. This encounter leads to bacterial killing 
under normal conditions; however, following injury or exposure to other detrimental 
factors, the immune response is suppressed allowing bacteria to survive and perhaps 
disseminate through the body (17-19).  
 When intestinal epithelial cells die, they are shed predominantly from the villus 
tip. The intestinal epithelium is replaced every 3-5 days indicating the need for an active 
stem cell population in the gut. Intestinal stem cells reside in the crypts of the intestine 
and, when needed, differentiate, proliferate, and move up the villus. Intestinal stem cells 
can become any of the different epithelial lineages including enterocyte, Paneth cell, or 
goblet cell (20). Maintenance of this stem cell population and subsequent differentiation 
is tightly controlled by gradients in the Wnt and bone morphogenic protein (BMP) 
signaling pathways. High Wnt signaling in the crypt maintains the stem cell population 
and prevents differentiation, except in Paneth cells where Wnt signaling is necessary for 
Paneth cell maturation (21). Transit amplifying cells are the immediate progeny of stem 
cells and as these cells move up the villus, Wnt agonists decrease and BMP agonist 
increase promoting differentiation into secretory (Goblet) or epithelial cells (22). 
 The intestinal epithelial barrier is a complex system balancing absorption of 
nutrients and protection from outside insults including commensal bacteria and ingested 
toxins or allergens. Although the intestinal barrier is constantly balancing these issues, in 
healthy individuals, no problems are apparent as IECs are replaced every 3-5 days to 
preserve the barrier. Unfortunately, most insults on the body perturb the intestinal barrier 
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itself or the immune component within the intestine. In some cases, both are altered 
causing even greater damage. Maintenance of the intestinal epithelial barrier is one of our 
bodies’ first lines of defense against ingested toxins and contaminants and determining 
mechanisms of how this barrier is affected after injury is important for preventing further 
damage and discovering treatments to aid in faster recovery. 
Myosin light chain kinase activation and intestinal permeability 
MLCK isoforms and activation 
 Activation of numerous signaling pathways, including cytokines, bacteria, 
traumatic injury, sodium transport, and ethanol (5, 23-26), can lead to cytoskeletal 
contraction, tight junction disruption, and ultimately, intestinal permeability. Ultimately, 
most of these pathways end up in the activation of myosin light chain kinase (MLCK) (5, 
24, 25). When examining permeability in an epithelial barrier, it is the long (210 kDa) 
form of smooth muscle MLCK that is being discussed. There are two genes for MLCK in 
vertebrates, one for skeletal muscle MLCK and the other for smooth muscle MLCK (27). 
Smooth muscle MLCK isoforms (long, 210 kDa and short, 130 kDa) are produced from 
the same gene but different promoters. The short and long forms of MLCK are very 
similar with the C-terminus and catalytic cores being exactly the same (28). Long MLCK 
does have an N-terminal extension consisting of two actin binding domains and six Ig 
domains (29). These actin binding domains allow MLCK to anchor to actin and bring the 
catalytic core in proximity of myosin light chain (MLC) so MLCK can phosphorylate 
MLC. Smooth muscle MLCK is ubiquitously expressed throughout the body; however, 
the long form is predominantly expressed in barrier tissues, such as the intestine, lung, 
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and kidney (27). MLCK activation is necessary for normal intestinal barrier function as it 
permits nutrient absorption and IEC proliferation. 
 Encoded in the MLCK protein is its own autoinhibitory sequence that blocks the 
catalytic core and prevents MLCK from phosphorylating MLC. In the presence of 
calcium (Ca
2+
), calmodulin is activated and can bind to MLCK causing the inhibitory 
domain to move and expose the catalytic core (30). Active caspase-3 can also cleave 
MLCK, removing the inhibitory domain thus producing a constitutively active MLCK 
(31). Although the autoinhibitory sequence blocks catalytic activity, it does not prevent 
ATP from binding. As soon as inhibition is released, MLCK can phosphorylate MLC 
(30). Once MLC has been phosphorylated (pMLC, Ser 19) it can interact with actin and 
initiates cytoskeletal contraction. 
Regulation of MLCK activation 
 As MLCK is a Ca
2+
-dependent enzyme, any pathway that generates calcium 
release has the potential to activate MLCK. G-protein coupled receptors (GPCR), 
particularly those with αq and α12/13 subunits, such as protease-activated receptors (PAR), 
and growth factors are a few common pathways known to initiate calcium release (6) 
(Figure 3). Additional to MLCK activation, several other key enzymes are also activated 
downstream of GPCR or growth receptor signaling that can regulate MLCK activity. The 
small GTPase, Rho, is one of these enzymes. Rho, when bound to GTP, can activate Rho 
kinase (ROCK) (32). ROCK is also a serine/threonine kinase and has been demonstrated 
to phosphorylate MLC’s activation site, serine 19 (33), but this is one of its minor targets. 
Recent work suggests that the role of ROCK in MLCK activation is through inactivation  
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Figure 3: MLCK activation can be regulated by different pathways. MLCK activation can 
be controlled by a variety of different pathways with the PAR-1 (GPCR) and EGFR 
pathway demonstrated. Following stimulation of PAR-1, α12/13 subunits can lead to the 
activation of Rho guanine exchange factors (Rho-GEF) which promote exchange of GDP 
for GTP thus initiating Rho function. Active Rho (Rho-GTP) can then bind ROCK, 
which phosphorylates myosin light chain phosphatase and inhibits its function. Other α 
subunits (αq) activate phospholipase C (PLC), ultimately triggering release of calcium. 
Calmodulin binds Ca
2+
 which when bound to the autoinhibitory domain of MLCK, 
released the inhibition and allows MLCK to phosphorylate MLC. In addition to calcium 
regulation, tyrosine phosphorylation of MLCK enhances its activity. Src kinase, known to 
be activated following interleukin-6 (IL-6) stimulation, can phosphorylate MLCK and 
augment its ability to phosphorylate MLC. 
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of MLCP more so than direct phosphorylation of MLC (34). Phosphorylation at threonine 
696 inhibits MLCP (35). When active, MLCP de-phosphorylates MLC consequently 
preventing its interaction with actin and cytoskeletal contraction. A balance between 
MLCK and MLCP activity (or inactivity) aids in the maintenance of the intestinal barrier 
and prevents intestinal permeability. ROCK also phosphorylates MLCP at threonine 850, 
which is a regulatory site and its significance is not known (36, 37). Finally, as previously 
mentioned, GPCR and PAR-1 signaling can also regulate MLCP activation. In addition to 
ROCK phosphorylation, CPI-17 (C-kinase potentiated protein phosphatase-1 inhibitor) 
binding also inhibits MLCP. CPI-17 must be phosphorylated to bind to MLCP and PKC 
is one known kinase for this modification of CPI-17 (38). Although CPI-17 has been 
revealed as a MLCP inhibitor, it is not known to be expressed in the intestine. In addition 
to the aforementioned proteins, MLCK activity is also regulated by phosphorylation of 
itself. Protein kinase C (PKC), a serine/threonine kinase is also calcium activated. PKC 
has many phosphorylation targets, but in relation to MLCK, it acts as an inhibitor. 
Phosphorylation within MLCK’s catalytic core or calmodulin binding site inhibits MLCK 
function, and both PKC (α and β) and PKA can phosphorylate this site (28). No other 
isoforms of PKC are known to phosphorylate MLCK; however, both PKCδ and PKCε are 
linked with TNFα-induced intestinal barrier dysfunction (250, 251). Furthermore, PKC 
and PKA also phosphorylate MLC thus decreasing MLCK’s affinity for MLC, and if 
MLC has already been phosphorylated at serine 19, phosphorylation at serines 1 and 2 or 
threonine 9 (PKC consensus sites) it has a decreased ability to bind to actin (39, 40).  
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 While PKC and PKA activity inhibit MLCK, Src kinase, can elevate MLCK 
activity. Within the N terminal extension of long MLCK are several Src consensus sites 
that when phosphorylated enhance MLCK activity (41). Furthermore, pro-inflammatory 
cytokines, particularly TNFα, IL-1β, and IL-6 have all been associated with augmented 
MLCK activation (24, 25, 42, 43). With numerous players involved in the regulation of 
MLCK activation (Figure 3), it becomes apparent that imbalance in either direction (too 
much MLCK activity or too little) may cause dire consequences for the intestine and the 
whole organism. 
 Consequences of an elevation in MLCK activity are observed in diseases, such as 
inflammatory bowel disease (IBD), as well as following infection, trauma, alcohol 
(ethanol) exposure (24, 25, 43, 44). Cytokines and MLCK activity have long been studied 
in the intestine, particularly TNFα and MLCK. Along with IBD, intestinal ischemia, and 
graft versus host disease are all linked with TNFα-induced MLCK activation (45-47). 
Interestingly, TNF-induced MLKC activity elevates paracellular permeability and anti-
TNFα antibody treatment has become prominent in management of IBD (48-50). Both 
injury and disease affects the entire body, but is worsened in part by the “gut-lymph 
hypothesis”. This hypothesis states that bacteria (or bacterial components) translocating 
from the intestinal lumen (through a damaged intestinal epithelium) move into the 
mesenteric lymph nodes where, if not killed, eventually end up being moved back into 
the bloodstream (125). Bacteria-laden blood is then free to circulate throughout the body 
promoting further systemic problems. With this knowledge, understanding the role of 
MLCK following insult becomes important in the treatment of a patient. 
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IL-6, intestinal homeostasis, and intestinal damage 
IL-6 signaling 
 IL-6 and IL-11, along with oncostatin M, leukemia inhibitor factor, and several 
others, make up a family of cytokines known primarily for their roles in inflammation. 
Using the IL-6 receptor (IL-6R) and gp130, IL-6 stimulates JAK3 activation which 
phosphorylates the transcription factor Stat3 (signal transducer and activator of 
transcription 3). Phosphorylated Stat3 then homodimerizes, and moves into the nucleus 
where it leads to the transcription of other pro-inflammatory cytokines, transcription 
factors, and an inhibitor to IL-6 signaling, SOCS3 (suppressor of cytokine signaling 3). 
SOCS3 inhibits JAK3 thereby limiting IL-6 signaling activity (51) (Figure 4). 
 Many cell types express IL-6R (52), such as hepatocytes, immune cells, and 
fibroblasts although its expression on enterocytes has been debated. (52, 53). Recently, a 
soluble form of IL-6R was reported (54). Soluble IL-6R could bind IL-6 and bind to any 
cell expressing gp130. This vastly enhances the number of IL-6 responsive cells as gp130 
is ubiquitously expressed (55). 
IL-6 is necessary for homeostatic functions 
 Although IL-6 is predominantly associated with inflammation, it is required for 
some normal cellular functions. Under healthy conditions, a nominal level of NF-κB 
signaling occurs in intestinal epithelial cells (56). IL-6, along with many other cytokines, 
induces NF-κB activation. This low level of NFκB activation does not cause an immune 
response, but instead, promotes cell survival and expression of anti-apoptotic genes (56). 
Inhibition of NF-κB causes intestinal damage and inflammation in the epithelial barrier  
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Figure 4: IL-6 signaling activates NF-κB, ERK, and Src kinase. IL-6 signaling through 
IL-6R and gp130 activates Stat3 leading to transcription of other cytokines, transcriptions 
factors and its own inhibitor, Socs3. IL-6 binds to IL-6R, recruits gp130 and initiates the 
signaling cascade, ultimately ending in the activation of NF-κB, pStat3 and other 
transcription factors. These factors induce expression of genes including other cytokines 
and SOCS3, an inhibitor to IL-6 signaling. Activation of the IL-6 signaling pathways also 
activates Src kinase, a kinase known to enhance MLCK activity. 
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(57). Loss of both IKK1 and IKK2 in intestinal epithelial cells led to development of 
colitis; however, knockout of only one IKK did not cause any epithelial damage (57). 
This would suggest that loss of one IKK is compensated for by the other enzyme. When 
NF-κB signaling is enhanced (in cases of infection, trauma, and chronic diseases) above 
this negligible level, it induces an inflammatory response. 
IL-6 and B cell and Th17 cell activation 
 Known by many names including interferon β2, B-cell stimulatory factor-2 and 
later T-cell-replacing factor, IL-6 was first discovered as a T cell-secreted protein that 
induced B cells to secrete immunoglobulins (58). Since then, IL-6 has been described as 
an anti-apoptotic signal to multiple myeloma cells as IL-6 up-regulates Stat3 leading to 
production of bcl-xL and mcl-1. This enhancement of anti-apoptotic proteins contributes 
to the chemotherapy resistance of myeloma cells (59). 
 Along with transforming growth factor β, IL-6 induces the differentiation of Th17 
cells (60, 61). Th17 cells are important for maintenance of mucosal immunity as they 
protect against pathogens such as Klebsiella pneumonia (61), and alteration of Th17 
cytokines, IL-17 and IL-22, is associated with inflammatory bowel disease (61). 
Moreover, IL-17 induces ERK signaling in intestinal epithelial cells which enhances 
expression of the tight junction protein, claudin-1 (62). 
IL-6 and immunosuppression 
 Increased IL-6 levels correlate with worse prognosis following injury (65, 66). In 
a model of ethanol exposure and burn injury, a rise in systemic IL-6 is associated with T 
cell suppression (67). Treatment with an IL-6 neutralizing antibody in the combined 
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injury model restored splenocyte proliferation and the DTH response (68). A similar 
immunosuppression was also observed in burn injury and sepsis patients (65, 66). IL-6 
induced immunosuppression contributes to a rise in susceptibility to infection following 
injury and during chronic diseases. 
IL-6, inflammation, and chronic diseases 
 Rheumatoid arthritis, obesity, IBD, and cancer are linked with elevated IL-6 
levels (69-72). In IBD, IL-6 provides an anti-apoptotic signal to T cells that accumulate 
in the intestine (73). This loss of T cell apoptosis enhances the continuous immune 
response which is characteristic of the disease. Furthermore, IL-6 regulates claudin-2 
expression (74). Elevations of claudin-2 (a “leaky” tight junction protein) inclusion in 
tight junctions increase the permeability of the junction which can promote further 
inflammation. Anti-IL-6 therapy represents another viable option for patients with 
chronic diseases and phase trials have been done in IBD patients as well as those 
suffering from arthritis (244, 245). 
Systemic effects of alcohol consumption 
Alcohol-induced health burden and drinking patterns 
 Despite high public awareness, alcohol (ethanol) continues to be one of the most 
abused drugs worldwide. Alcohol is a risk factor for infection, disease, and injury and 
contributes to nearly 4% of global deaths (75). Furthermore, both ethanol-induced 
mortality and ethanol-associated diseases were vastly higher in people under the age of 
60, with the 15-29 and 30-44 age groups displaying the biggest ethanol effects (75). Less 
than 10% of drinkers in the United States are considered chronic or dependent, indicating 
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that most consumers are acute (occasional), moderate or binge drinkers. (76). A drink is 
defined as 12 oz. of beer, 5 oz. of wine, or 1.5 oz of liquor (77), and several different 
patterns of ethanol consumption exist. As defined by the National Institute on Alcohol 
and Alcoholism moderate or acute (“low risk”) drinking consists of no more than 14 
drinks per week (2-3 per day) for men or no greater than 7 drinks per week (1-2 per day) 
for women. Binge drinking is classified as consuming enough ethanol to bring the blood 
alcohol content (BAC) above the legal limit of 0.08 mg/dL in 2 hours. Men can usually 
attain this BAC with 5 drinks while only 4 drinks will bring the BAC to this level in 
women (77). Chronic drinking is defined as greater than 8 drinks per day for many days 
(77).  
Acute ethanol and cellular immune defects 
 Even short term ethanol exposures (acute and binge) can affect both the innate 
and adaptive immune responses. Acute ethanol has been demonstrated to decrease the 
pro-inflammatory cytokine response to microbial compounds like lipopolysaccharide 
(LPS), peptidoglycan, and polyinosinic-polycytidylic acid (poly I:C) (17, 78, 79). 
Suppression of NF-κB activity also occurs following ethanol exposure and LPS challenge 
(80). Decreased ethanol-induced inflammatory responses lead to a rise in susceptibility to 
infection. Besides reduced production of cytokines, acute ethanol also dampens the 
phagocytic ability of macrophages and other antigen-presenting cells (81, 82). Inability to 
phagocytose pathogens not only permits these damaging organisms to survive, but it 
disrupts the communication between the innate and adaptive immune systems. Without 
phagocytosis, antigen presenting cells cannot present bacterial components to T cells, 
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further suppressing the immune response. Surprisingly, human studies indicate decreased 
levels of monocyte antigen presentation after only one alcohol exposure (82). In addition 
to less phagocytosis, acute ethanol has also been shown to reduce dendritic cell activation 
of T cells (82, 83). 
Chronic ethanol effects on the cellular immune response 
 Interestingly, chronic ethanol exposure has an opposite effect on the innate 
immune response following lipopolysaccharide (LPS) challenge. Elevated production of 
inflammatory cytokines and NF-κB activation are associated with chronic ethanol 
exposure (84). Furthermore, fewer bone marrow-derived dendritic cells were observed in 
a chronic ethanol mouse model (85) and similar to acute ethanol, chronic levels of 
ethanol cause reduced phagocytosis (86, 87).  
Ethanol-induced alterations to the adaptive immune system also occur. Elevated 
immunoglobulin (Ig) levels are commonly found in alcoholics (88). Despite a rise in Ig’s, 
a decrease in B cells was found in alcoholics although mouse models suggest that there is 
no effect of ethanol on B cell function (89). This elevation in Ig’s is actually associated 
with greater immunodeficiency as many of the Ig’s produced are against self-targets 
including lymphocytes, DNA, serum lipoproteins, and several liver proteins (90). Both 
acute and chronic ethanol exposure cause modifications in T cell function and activation. 
As previously mentioned, acute ethanol decreases antigen presentation, thereby reducing 
T cell activation. Moreover, T cell proliferation diminishes as is expression of co-
stimulatory molecules following exposure to ethanol (82). Overall, these studies suggest 
severe alterations in immune cell action after both acute and chronic ethanol exposure.  
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Review of ethanol’s effects on liver and brain 
 In addition to immune system defects, many if not all tissues of the body 
experience changes due to ethanol exposure. This subject has been extensively described 
in the literature, particularly ethanol-induced alterations to the brain and liver (91). 
Briefly, Kupffer cells (resident liver macrophages) produce elevated tumor necrosis 
factor-α (TNFα) and reactive oxygen species (ROS) in response to chronic ethanol (92, 
93). Circulating LPS, commonly found in alcoholics, causes Kupffer cells to release IL-
1β, IL-6 and chemokines (92, 94). All of these mediators promote inflammation, cell 
death, and fibrosis in the liver and represent characteristics of alcoholic liver disease (92, 
93). Similarly, the inflammatory cytokines TNFα, IL-1β, monocyte chemoattractant 
protein-1 (MCP-1), and inducible nitric oxide synthase (iNOS) are up-regulated in the 
brain following ethanol exposure (95). Interestingly, an elevation in cytokines was 
actually also found in the brains of alcoholics and as were cell death biomarkers (96). 
Alcohol-induced brain damage is diffuse and widespread and known to cause social 
withdrawal, and attention and impulse-control deficits (97, 98). 
Increased susceptibility for lung damage following ethanol exposure 
 Despite ethanol’s primary association with neurological and liver damage, both 
the lung and intestine are also greatly influenced by ethanol exposure. Surprisingly, more 
patients in the United States die from alcohol-related lung dysfunction than liver cirrhosis 
(91) and chronic ethanol abuse is a risk factor for development of acute respiratory 
distress syndrome (99). The resident immune cells of the lung, primarily alveolar 
macrophages, display reduced phagocytosis and superoxide production following ethanol 
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exposure and bacterial challenge (100, 101). Lungs are highly vascularized which is 
necessary for oxygen exchange, but this characteristic also exposes this tissue to 
increased inflammatory mediators, ROS, and pathogens in the bloodstream. As already 
discussed, ethanol exposure causes an increased risk for infection and interestingly, 
chronic ethanol also reduces glutathione (102, 103). Glutathione is the major scavenger 
of excess ROS in the body. Metabolism of ethanol produces ROS, suggesting that excess 
ROS in the bloodstream combined with reductions in glutathione may also contribute to 
lung tissue injury (104). 
Intestinal permeability, inflammation, and damage following ethanol 
 Finally, the first organ system to encounter ethanol after exposure is the 
gastrointestinal system. Both acute and chronic ethanol exposure trigger alterations to the 
structure of the entire tract (105, 106). Even acute ethanol exposure can cause intestinal 
damage, which is characterized by loss of the intestinal epithelium, particularly at the tips 
of villi, and infiltration of inflammatory cells (106). Chronic ethanol exposure produces 
more severe changes in intestinal morphological, as villi are often blunted following long 
term ethanol (105). Furthermore, intestinal permeability, MLCK activation, and intestinal 
pro-inflammatory levels rise with chronic ethanol exposure (24, 107, 108). Elevations in 
permeability are further associated with reduced localization of tight junction proteins, 
ZO-1 and occludin, to the junction (109, 110). Bacterial overgrowth and dysbiosis 
(abnormal microbiota composition) are also both induced with exposure to ethanol (111). 
Considering how extensively ethanol is abused, studies presented in this section indicate 
that ethanol has the potential to cause serious whole body damage. 
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Burn injury, inflammation, and intestinal permeability 
A clinical perspective on burn injury 
 There are more than 1 million burn-related injuries in the United States each year, 
resulting in approximately 50,000 hospitalizations and 3,500 deaths (112). Burn injury, 
like many traumatic injuries, results in increased circulating levels of pro-inflammatory 
cytokines (113, 114), known as systemic inflammatory response (SIRS) (18, 115). Some 
trauma patients also develop compensatory anti-inflammatory response syndrome 
(CARS) increasing their risk for infection. Nearly 50% of burn patients suffer infectious 
complications during their time in the hospital (116). Deaths due to sepsis remain 
unchanged despite improvements in resuscitation and wound treatment. These 
observations indicate that burn patients are highly susceptible to infection and that the 
source of said infection may come from within the patient. Although the consequences of 
burn injury seems like they should be restricted to the skin, the opposite is actually closer 
to reality. Burn injures cause systemic complications, helping explain why multiple organ 
failure and multiple organ dysfunction syndrome are the two most common causes of 
death following burn (117, 118).   
Lungs and multiple organ dysfunction following burn injury 
 Similar to many tissues, a rise in inflammatory mediators is evident in the lung 
(119) after burn injury. Inhalation combined with burn injury further amplifies these 
mediators, in particular IL-6 and monocyte chemotactic protein 1 (MCP-1) (120). SIRS 
causes lung tissue damage soon after insult partially due to their high vascularization and 
delicate architecture. Augmented levels of chemokines in the lungs recruit neutrophils, 
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which can kill invading pathogens, but can also damage delicate epithelial cells as well 
(121, 122). The lung epithelia constitute the walls of the alveoli and if damaged, reduce 
gas exchange and lung function. This pulmonary damage induces lung failure and the 
lungs are the first organ to fail in cases of multiple organ dysfunction syndrome (MODS) 
and multiple organ failure (MOF), the two most common causes of death in burn patients. 
Burn injury induces intestinal inflammation and permeability 
 Edema formation at the burn site is evident early after insult in both humans and 
rodent models (122, 123). This edema transpires at the expense of other organs, such as 
the intestine, where water loss is evident. Animal models have demonstrated that burn 
injury causes mesenteric vasoconstriction and splanchnic vasoconstriction (123, 124). 
Both types of blood/lymph constriction trigger gut mucosal damage and bacterial 
translocation (125). Although controversial, bacterial translocation to the mesenteric 
lymph nodes (MLN) does occur in humans following some intestinal insults (125, 126). 
Intestinal permeability rises following burn injury in both lab models and in burn patients 
(127, 128) and numerous cytokines and chemokines, including IL-6 and KC (a neutrophil 
chemokine) increase in the ileum following burn injury (113). Further enhancing 
intestinal damage, chemokines, like KC and macrophage inflammatory protein 2 (MIP-
2), recruit neutrophils to the tissue. Once in the intestine, neutrophils release various 
enzymes which aid in the killing of pathogens, but too many neutrophils can lead to 
tissue damage (129-131). IL-6, TNFα, IL-8 (human homolog of mouse KC and MIP-2), 
and LPS have all been demonstrated to inhibit neutrophil apoptosis (132-134). Elevated 
inflammatory cytokines and tissue damage are strong activators of MLCK, and not 
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surprisingly, MLCK activation increases in IECs in animal models of burn injury (135). 
Augmented MLCK activation is associated with intestinal morphological damage, 
decreased ZO-1, occludin, and claudin-1 protein levels, and intestinal permeability (135, 
146). Inhibition of MLCK or inflammatory cytokine expression reduces burn-induced 
intestinal damage and permeability and restores tight junction protein levels in the 
intestinal epithelial barrier (135, 146). Using a rat model, Shao and colleagues discovered 
amplified occludin expression following burn injury although it was not localized to tight 
junctions (136). As occludin must be phosphorylated for inclusion in the junction 
complex, this suggests that burn injury may alter either kinases responsible for 
phosphorylating occludin or the phosphatases removing the phosphate mark. 
Additionally, exposure to burn serum reduced vascular endothelial cadherin and β-
catenin at adherens junctions in endothelial cells (137). Burn injury also stimulates 
bacterial growth (138) which, when combined with burn-induced alterations in junction 
complexes, creates an ideal situation for bacterial translocation and possible systemic 
dissemination of these bacteria. 
Ethanol exposure and burn injury, a “second hit” yields additional problems 
Effects of ethanol and burn injury in the clinic 
 As already mentioned, ethanol is a risk factor for injury, infection, and surgical 
complications (76, 139). Nearly 50% of the adult burn patient population has a positive 
blood alcohol content at the time of admission (140-142). Clinical data from the Burn 
Intensive Care Unit at Loyola University Chicago indicate that despite the fact that 
ethanol-exposed burn patients have smaller burn sizes than their non-intoxicated 
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counterparts, they spent just as many days in the hospital and accrued the same amount of 
hospital costs (143). Ethanol exposure prior to burn injury also increases both morbidity 
and mortality (76, 140). Further clinical studies indicate that intoxicated burn patients had 
a rise in intensive care unit admissions, days on the ventilator, and fluid resuscitation 
requirements as compared to burn patients who were not intoxicated. Additionally, 
pneumonia and hypotension occurred more often in patients who were intoxicated at the 
time of burn when compared to burn patients who had no alcohol in their blood stream 
(139, 142).   
Ethanol, burn injury, and the systemic immune response 
 The combined insult of ethanol exposure and burn injury generates an 
immunosuppressed cellular immune response which is characterized by a reduced 
delayed type hypersensitivity (DTH) response and decreased splenocyte activation and 
proliferation (144, 145). Enhanced systemic IL-6 levels contribute to this 
immunosuppression as anti-IL-6 antibody treatment restores the DTH response and 
splenocyte proliferation (68). In addition, the combined insult produces an elevated 
inflammatory state in tissues like the lung and intestine (147, 148).  
Effect of the combined insult on the lung 
 The “gut lymph hypothesis”, which suggests that bacterial translocation into the 
lymphatic system can harm other tissues, is especially important when discussing the 
lung. The contents of the lymphatic system move back into the bloodstream at the 
thoracic duct, so the first capillary bed and tissue encountered by bacteria-laden blood is 
the lung. With its delicate architecture and extensive vascularization, the lungs are highly 
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susceptible to tissue damage and inflammation. This susceptibility is observed following 
ethanol exposure and burn injury. After the combined insult, intracellular adhesion 
molecule 1 (ICAM-1), and KC are elevated in the lung and this is associated with 
increased neutrophil infiltration (148). Despite this rise in neutrophils, reduced bacterial 
clearance is observed following the combined insult and intratracheal bacteria challenge 
(149). Furthermore, ethanol-exposed and burn-injured mice display thicker alveolar walls 
and greater tissue damage than mice exposed to either insult alone (148, 150). Reduced 
alveolar space and thicker alveolar walls will decrease lung function and oxygen 
exchange leading to lung dysfunction and failure. 
Intestinal response to ethanol exposure and burn injury 
 A similar state of inflammation occurs in the ileum of mice exposed to ethanol 
and burn injury. IL-6, IL-18 and chemokines CINC 1/2 (rat homologs of KC and MIP-2) 
are elevated in the ileum following the combined insult. This rise in neutrophil 
chemoattractants trigger elevated neutrophil infiltration and ROS leading to tissue 
damage (151, 152). Ethanol exposure and burn injury reduce occludin and claudin-1 in 
the intestinal epithelial layer and a rise in apoptosis was also observed in the ileum 
following the combined insult. Interestingly, inhibition of IL-18 attenuates neutrophil 
infiltration, intestinal permeability, and apoptosis and restores occludin and claudin-1 
levels in a mouse model of the combined insult (152-154). Additionally, T cells in the 
MLN and Peyer’s patches exhibit diminished activation, proliferation, and IL-2 and 
interferon γ (IFNγ) in mice exposed to ethanol and burn injury (155). This suggests that 
any bacteria that do get into the MLN or lamina propria may survive. As observed 
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following either injury alone, the combined insult also generates bacterial overgrowth 
(156) further demonstrating the importance of an intact epithelial barrier. 
 Other animal models demonstrate similar intestinal responses following combined 
insults. Using a model of intestinal ischemia/reperfusion and intestinal infection, Kubiak 
and colleagues discovered severe intestinal edema, epithelial sloughing and flattened villi 
following these insults (246). As infection and sepsis are common after burn injury, a 
model of burn and Enterococcus faecalis infection was employed to investigate intestinal 
permeability, a possible second source of infection. This second hit of infection led to 
greater intestinal permeability and decreased occludin expression than either insult alone 
(247). These two models indicate the importance of an intact intestinal barrier following 
not just one insult, but also in cases of combined injury. 
 Absorption of some nutrients requires intestinal permeability, but this is a highly 
controlled and short-lived occurrence. When intestinal permeability is prolonged, as 
observed following disease, injury, or ethanol exposure, intestinal tissue damage and 
inflammation occurs. The combination of ethanol exposure and burn injury elevates 
intestinal permeability greater than either insult alone (156). Bacterial translocation takes 
place when the IEC layer is damaged; however, with a rise in intestinal permeability, 
bacteria and other luminal contents can enter the lamina propria through areas of 
damaged epithelium as well as gaps in the epithelial barrier. Once in the lamina propria, 
these bacteria are normally killed by macrophages; however, in cases of 
immunosuppression or overwhelming numbers of bacteria, some microbes may survive 
and accumulate in the lymphatics, specifically the mesenteric lymph nodes. This allows 
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for the potential of systemic bacterial infection and inflammatory responses. While 
knowledge of the immune parameters occurring in the gut following ethanol exposure 
and burn injury exists, the mechanisms leading to intestinal permeability are not well 
understood.  
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CHAPTER 3 
 INHIBITION OF LONG MYOSIN LIGHT CHAIN KINASE ACTIVATION 
ALLEVIATES INTESTINAL DAMAGE AFTER BINGE ETHANOL EXPOSURE 
AND BURN INJURY 
Abstract 
 Laboratory evidence suggests that intestinal permeability is elevated following 
either binge ethanol exposure or burn injury alone and this barrier dysfunction is further 
perturbed when these insults are combined.  We and others have previously reported a 
rise in both systemic and local pro-inflammatory cytokine production in mice after the 
combined insult.  Knowing that long myosin light chain kinase (MLCK) is important for 
epithelial barrier maintenance and can be activated by pro-inflammatory cytokines, we 
examined whether inhibition of MLCK alleviated detrimental intestinal responses seen 
after ethanol exposure and burn injury.  To accomplish this, mice were given vehicle or a 
single binge ethanol exposure followed by a sham or dorsal scald burn injury.  Following 
injury, one group of mice received PIK (membrane permeant inhibitor of MLCK).  At 6 
and 24 hours post-injury, bacterial translocation and intestinal levels of pro-inflammatory 
cytokines were measured and changes in tight junction protein localization and total 
intestinal morphology were analyzed.  Elevated morphological damage, ileal IL-1β and 
IL-6 levels, and bacterial translocation were seen in mice exposed to ethanol and burn 
injury relative to either insult alone.  This increase was not seen in mice receiving PIK 
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after injury.  Ethanol-exposed and burn-injured mice had reduced zonula occludens 
protein-1 (ZO-1) and occludin localization to the tight junction relative to sham-injured 
mice.  However, the observed changes in junction complexes were not seen in our PIK-
treated mice following the combined insult.  These data suggest that MLCK activity may 
promote morphological and inflammatory responses in the ileum following ethanol 
exposure and burn injury.  
Introduction 
Nearly 1 million burn injuries occur annually in the United States with 
approximately 4,000 patients succumbing to their injuries (112).  Both clinical and 
laboratory studies indicate that intestinal permeability and tissue injury increase after 
burn injury permitting bacteria to translocate into the lymphatic system and ultimately the 
bloodstream (125, 135).  In a rodent model of binge ethanol exposure and burn injury, 
Kavanaugh et al. demonstrated that the combined insult promotes greater bacterial 
translocation to the mesenteric lymph nodes (MLN) and intestinal permeability than in 
mice receiving either treatment alone (63, 156).  The distal small intestine and colon 
contains enormous volumes of bacteria (10
5
-10
8
 bacteria per gram of tissue) and 
endotoxin; therefore, changes in intestinal permeability could produce systemic 
complications.  Intestinal barrier dysfunction/failure allowing gut flora and its 
components to invade the intestinal mucosa is the basis for the gut-lymph hypothesis of 
multiple organ dysfunction syndrome (MODS) (64), which states that traumatic injury 
promotes a rise in intestinal permeability leading to a release of bacteria and endotoxin 
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into the lymphatic system and ultimately the bloodstream.  As the bacteria-laden blood 
encounters the lung vascular bed first, pulmonary injury is possible thus promoting the 
early stages of MODS (64, 157) and ultimately multiple organ failure (MOF), which are 
the two most common causes of death after burn injury (158, 159). 
 Intestinal epithelial cells, physically connected by multiple types of junction 
complexes, create a semi-permeable mucosal barrier, which permits absorption of 
nutrients but prevents other contents of the lumen from entering the lamina propria (160, 
161).  Regulation of this barrier can be affected by various stimuli, including bacteria, 
cytokines, traumatic injury, and ethanol (23-25, 125).  Junction proteins, such as the tight 
junction proteins zonula occludens protein-1 (ZO-1) and occludin, as well as enzymes 
important for the maintenance of this barrier can be affected by these stimuli.  One such 
enzyme, long (210 kDa) myosin light chain kinase, phosphorylates myosin regulatory 
light chain (MLC) at serine 19 allowing it to interact with actin.  Myosin-actin interaction 
causes cytoskeletal sliding, which induces tight junction disruption and a gap in the 
epithelial barrier.  Actin reorganization, elevated permeability, and ZO-1 and occludin 
redistribution away from tight junctions are associated with MLC phosphorylation (109, 
110). 
Inflammatory diseases and traumatic injury amplify pro-inflammatory cytokines 
in the gut (158, 162).  A rise in pro-inflammatory cytokines is associated with MLCK 
activation and it has been shown that TNF-, IL-1β, and lymphotoxin-like inducible 
protein that competes with glycoprotein D for herpesvirus entry mediator on T cells 
(LIGHT) can up-regulate MLCK transcription (25, 42, 49, 163).  Furthermore, increased 
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MLCK activation has been linked to intestinal permeability after burn injury or chronic 
ethanol exposure alone (24, 164). Traumatic injury, like burn, causes an over-exuberant 
systemic inflammatory response characterized by a rise in systemic and tissue levels of 
IL-6, TNF-, and IL-1 (19, 68, 145, 165).  When injury is combined with ethanol 
exposure, these immune responses are often further increased. Recently, a specific 
MLCK inhibitor, PIK, was found to reduce occludin reorganization away from tight 
junctions and restore water absorption in a model of T cell-mediated diarrhea (166). 
Moreover, TNFα and interferon-γ–induced barrier dysfunction was reversed with PIK 
treatment (167). 
Ethanol is a common risk factor in traumatic injury (76, 168), and approximately 
50% of the adult burn patient population has a positive blood alcohol content at the time 
of admission (140, 141).  Further evidence suggests that the combination of ethanol and 
burn injury leads to enhanced immunosuppression promoting greater susceptibility to 
bacterial infection at both the wound site as well as remote organs, such as the lung and 
ileum (169-171). 
The combination of insult-induced immunosuppression and inflammation along 
with amplified bacterial translocation in the gut contribute to a physiological state that is 
ideal for tissue destruction and dysfunction.  We hypothesized that inhibition of MLCK 
would alleviate the intestinal damage and inflammatory responses seen after binge 
ethanol exposure and burn injury.  Mice had greater villus blunting and edema as well as 
a redistribution of ZO-1 and occludin following ethanol and burn injury compared to 
sham treated mice.  These changes coincided with elevated phosphorylated myosin light 
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chain (pMLC), bacterial translocation and ileum IL-6 levels.  In contrast, PIK-treated 
mice exposed to ethanol and burn injury had significantly reduced intestinal damage, 
normal tight junction protein localization, and decreased bacterial translocation and IL-6.  
This indicates a crucial role for MLCK in intestinal barrier leakiness and/or inflammation 
in our model of ethanol and burn injury.   
Materials & Methods 
Mice 
 Eight to ten week old male (C57BL/6, 23-25 grams,) mice were purchased from 
Jackson Laboratories (Bar Harbor, ME).  Mice were housed in sterile microisolator cages 
in the Loyola University Medical Center Comparative Medicine facility.  All experiments 
were conducted in accordance with the Loyola Institutional Animal Care and Use 
Committee. 
Murine Model of Ethanol and Burn Injury 
 A murine model of a single binge ethanol exposure and burn injury was 
performed as described previously (172) with minor modifications (149).  Briefly, mice 
were given a single binge dose of 1.11 g/kg of 20% (v/v) ethanol solution 
intraperitoneally that resulted in a blood ethanol level of 150-180 mg/dl at 30 minutes.  
The mice were then anesthetized with 100 mg/kg of Ketamine and 10 mg/kg of Xylazine 
(Webster Veterinary, Sterling, MA), their dorsum shaved, and placed in a plastic template 
exposing 15% of the total body surface area (TBSA) and subjected to a scald injury in 
90-92° C water bath or a sham injury in room-temperature water.  The scald injury 
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resulted in an insensate, full-thickness burn injury of approximately 15% total body 
surface area (173).  Mice received 1 mL of saline resuscitation and their cages were 
placed on warming pads until mice recovered from anesthesia.  At 30 minutes after burn 
injury, mice were given the specific long MLCK inhibitor PIK (i.p, 50 uM) (174).  Mice 
were sacrificed by CO2 narcosis followed by cervical dislocation at 2, 3, 6, or 24 hours 
following injury. 
Histopathologic examination of the ileum 
 At 6 and 24 hours post-injury, mice were euthanized by CO2 narcosis and the 
ileum was harvested and fixed overnight in 10% formalin. Samples were then embedded 
in paraffin, sectioned at 5 microns, and stained with hematoxylin and eosin (H&E).  
Images were taken at 200x. 
Immunofluorescent staining of ZO-1 and occludin in the ileum 
 Immunofluorescent staining was done as previously described (167) with minor 
modifications. Briefly, a small section of ileum (5 mm) was embedded in OCT and 
frozen for immunofluorescent staining.  The ileum was sectioned (5 microns) and stained 
with either rabbit anti-ZO-1 or rabbit anti-occludin (Invitrogen, Carlsbad, CA) followed 
by goat anti-rabbit Alexa 488 (Invitrogen, Carlsbad, CA).  Sections were further stained 
with fluorescent-conjugated phalloidin (actin) and Hoechst nuclear stain (Invitrogen, 
Carlsbad, CA).  Using Zeiss software (Zeiss LSM 510 Version 4.2 SP1), a 20 epithelial 
cell section (crypt or villus) was outlined and only within this outlined section were the 
number of co-localized (both red and green fluorescence) pixels determined.  The number 
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of co-localized pixels was divided by the total number of pixels in that section and 
expressed as a percentage.  This process was repeated an additional 4 epithelial cell 
sections per animal leading to 100 total epithelial cells examined for each animal.  
Results were averaged for each animal and this average was then used to determine the 
group average. 
Bacterial translocation 
 Bacterial translocation was assessed as previously described with minor 
modifications (156).  Briefly, 5-6 mesenteric lymph nodes (MLN) per mouse were 
removed at 6 or 24 hours, placed in cold RPMI and kept on ice.  Nodes were separated 
from connective tissue and homogenized in RPMI using frosted glass slides.  
Homogenates were plated in triplicate on tryptic soy agar (TSA) plates and placed in a 
37
o
C incubator overnight.  Colonies were counted the following day, averaged, and 
divided by the total number of lymph nodes harvested. 
Intestinal epithelial cell isolation and western blotting 
 Intestinal epithelial cells were isolated as previously described (167) with minor 
modifications.  Briefly, ileum sections were opened lengthwise, washed with calcium and 
magnesium free Hanks Basic Salt solution (HBSS), and placed in tubes containing 10 
mM DTT and phosphatase inhibitor cocktail in HBSS.  Samples were placed at 4
o
C for 
30 minutes, after which tubes were shaken briefly and ileum sections moved to tubes 
containing 1 mM EDTA and phosphatase inhibitor cocktail in HBSS for 1 hour at 4
o
C.  
After incubation, tubes were shaken robustly and large pieces of tissue removed.  
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Samples were centrifuged at 1000 g for 10 minutes and the supernatant discarded.  
Intestinal epithelial cells were confirmed through microscopy and villin 1 staining. 
Pelleted cells were lysed in 100 uL of Cell Lysis Buffer according to manufacturer’s 
protocol (BioRad, Hercules, CA). Twenty milligrams of whole cell lysate protein was 
boiled for 5 minutes, separated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), transferred to polyvinylidene fluoride (PVDF) membranes 
and blotted with primary antibodies specific for phopshorylated myosin light chain 
(pMLC Ser19, Cell Signaling Technology, Danvers, MA), total MLCK (Abcam, 
Cambridge, MA), and villin-1 (Cell Signaling Technology).  
Detection of Circulating Cytokine Levels 
 Blood was collected from cardiac puncture and serum was obtained by 
centrifugation after clotting. IL-6 and TNFα levels were then determined using ELISA 
according to manufacturer’s instructions (BD Biosciences, San Diego, CA). 
Cytokine determination and ileum 
 Two one-inch sections of ileum were homogenized in 1 mL of Cell Lysis Buffer 
according to manufacturer’s protocol (BioRad, Hercules, CA).  Homogenates were then 
filtered and analyzed for IL-6 levels using ELISA (BD Biosciences, San Diego CA).  The 
results were normalized to total protein present in the homogenate using the BioRad 
protein assay based on the methods of Bradford (175) (BioRad, Hercules, CA). 
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Statistical Analysis 
 Statistical comparisons (GraphPad Instat and Prism) were made between the sham 
vehicle, sham ethanol, burn vehicle, and burn ethanol treatment groups, resulting in 4 
total groups analyzed.  One-way analysis of variance was used to determine differences 
between treatment responses, and Tukey’s post-hoc test once significance was achieved 
(p < 0.05).  Statistical comparisons made between the burn ethanol and burn ethanol plus 
PIK treatment groups were done using student’s t-test and Tukey’s post-hoc test 
(p<0.05).  
Results 
 Following exposure to binge ethanol and burn injury a rise in IL-6 and intestinal 
permeability as well as a shortening of villus heights has been observed in the ileum 
(147).  These changes can promote further tissue damage and may contribute to systemic 
complications.  We sought to determine whether inhibition of MLCK after insult 
alleviates these detrimental responses. 
MLCK activated early after insult 
 TNF often peaks early systemically after injury (176) and we see an increase in 
serum levels at 2 hours post ethanol exposure and burn injury (Figure 5A). Interestingly, 
IL-6 levels, thought to peak at later time points, were also significantly elevated in the 
serum at 2 hours post insult (Figure 5B). Neither TNFα nor IL-6 is significantly elevated 
in ileum tissue (Figure 5C, D); however, we do see an increase in total MLCK in 
intestinal epithelial cells isolated from ethanol-exposed and burn-injured mice (Figure 
6A) at 3 hours post combined insult.  This elevation was not significant, but dually 
38 
 
A
B
*
*
*
*
Serum C
D
Ileum
 
Figure 5: TNFα and IL-6 elevated in serum at 2 hours post insult. Levels of TNFα and 
IL-6 in the serum (A, B) and ileum (C, D) were quantified by ELISA. Cytokine 
concentrations were normalized to total protein in ileum samples (C, D) as determined by 
BioRad protein assay and all data is presented as concentration  SEM. *p<0.05 versus 
both sham groups. n = 3-6 per group. 
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Figure 6: Ethanol exposure and burn injury elevates total MLCK and pMLC (Ser19) in 
intestinal epithelial cells. Isolated intestinal epithelial cells were lysed and analyzed by 
western blot for levels of MLCK (A) and pMLC (B, C) 3 hours after exposure to 
treatment. Quantification of MLCK and pMLC levels were normalized to villin-1 levels 
and done using BioRad Image Lab software.  Images are representative of 3 experiments, 
*p<0.05 versus all other groups, # p<0.05 versus Burn ethanol + PIK group. 
Quantification is of n = 6-8 per group. 
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exposed mice did have a significant increase in pMLC as compared to all other groups 
(Figure 6B) and PIK treatment significantly reduced pMLC following ethanol exposure 
and burn injury (Figure 6C). These data suggest that within a few hours of the combined 
insult the MLCK pathway has been activated, possibly due to elevated serum levels of 
TNFα and IL-6. 
Morphological damage observed by 6 hours post ethanol exposure and burn injury 
 Intestinal damage, characterized by villus blunting and edema as well as intestinal 
inflammation, commonly occurs after traumatic injury (43, 177, 178). Six hours after 
exposure to ethanol and burn injury, ileum morphology begins to change.  Mice in both 
burn groups had blunted villi (Figure 7C, D) as compared to mice in either sham group 
(Figure 7A, B).  The intestinal epithelial layer is also altered in mice exposed to the 
combined insult with gaps appearing between epithelial cells, although no changes in 
ZO-1 or occludin localization were observed at this time (data not shown).  Inhibition of 
MLCK using PIK yields to little or no change in the intestinal epithelial barrier 
morphology following exposure to ethanol and burn injury (Figure 7E).   
 After either traumatic injury or chronic ethanol exposure, bacterial translocation 
was reported to be elevated as a result of epithelial cell damage, bacterial overgrowth, 
epithelial barrier permeability and MLN T-cell suppression (155, 156).  This 
translocation occurs in small amounts in healthy individuals and under normal conditions 
MLN resident T cells clear the bacteria (155). Six hours after ethanol exposure and burn 
injury mice had significantly greater bacterial accumulation in the MLN when compared 
to all other groups (Figure 7F).  This elevation in bacterial accumulation was associated  
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Figure 7: PIK treatment reduces morphological damage and inflammation at 6 hours post 
combined insult. Ileum sections were stained with hematoxylin and eosin (A-E) and 
examined for degree of inflammation and damage. n= 6-8 per group. Mesenteric lymph 
nodes were isolated from mice sacrificed at 6 hours following insult (F), homogenized 
and plated on tryptic soy agar (TSA) plates. Colonies were counted the next day and 
normalized on the total number of lymph nodes removed from each mouse. Levels 
presented as concentration  SEM.  n = 6-10 per group. Ileum levels of IL-1β and IL-6 
were quantified by ELISA (G, H) and normalized to total protein. Data presented as 
concentration  SEM. *p<0.05 versus all groups except the sham ethanol group. &p<0.05 
versus sham vehicle and burn vehicle. n = 3-6 per group. @p<0.05 versus sham vehicle. 
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with a rise in ileum levels of IL-1β and IL-6 (Figure 7G, H).  PIK treatment significantly 
reduced bacterial accumulation in the MLN of mice given ethanol and burn injury and 
also decreased IL-1β in the ileum (Figure 7G).  These data indicate the continued 
inhibition of MLCK preserves intestinal morphology and reduces inflammation following 
ethanol exposure and burn injury. 
PIK treatment alleviates intestinal epithelial barrier alterations 
 Previous work in this model has revealed that the heights of villi are lower at 24 
hours following the combined insult (147). This response was verified in these 
experiments as villi in mice exposed to burn alone or the combined insult (Figure 8C, D) 
had shorter (115 μm ± 9) and wider villi than sham treated animals (200 μm  ± 14, 
p<0.05, Figure 8A, B).  Furthermore, there was a decrease in intact villi and the epithelial 
cell layer in mice given ethanol and burn injury as compared to all other groups. As seen 
at 6 hours, PIK treatment was coupled with reduced intestinal morphological damage 
(Figure 8E) as mice given PIK after ethanol and burn injury had tall (170 µm ± 9) and 
narrow villi similar to villi seen in sham treated mice. Since greater gross morphological 
changes/damage were observed at 24 hours following insult, we examined the effect of 
ethanol and burn injury on the localization of two of the major tight junction proteins in 
the ileal epithelial cell layer, ZO-1 and occludin (2).  Intact tight junction complexes in 
the intestinal epithelial layer prevent bacteria and their products from moving into the 
lamina propria and initiating an immune response. Representative images from wild type 
sham vehicle and sham ethanol mice (Figure 8F, G) show ZO-1 in its characteristic 
chicken wire pattern and its co-localization with actin indicating an intact tight junction.  
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Figure 8: MLCK inhibition preserves intestinal morphology and tight junction protein 
localization following ethanol exposure and burn injury. Ileum sections from mice were 
stained with hematoxylin and eosin (A-E) and then examined for degree of inflammation 
and damage.  Representative H&E images taken at 200x.  Frozen ileum sections were 
stained with antibodies against ZO-1 (green, F-J) or occludin (green, K-O) as well as 
phalloidin (red) and nuclei (blue).  Representative immunofluorescent images taken at 
400x. n = 6-8 per group. Immunofluorescent images were analyzed for co-localization of 
ZO-1 or occludin with actin (P, Q). Co-localization is presented as % colocalized 
pixels/100 epithelial cells. *p<0.05 versus all groups except burn vehicle. #p<0.05 versus 
sham groups. n = 4-6 per group. 
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Animals exposed to burn injury alone had a slight, but insignificant, decrease in ZO-1 
localizing with actin (Figure 8H), while almost no ZO-1 co-localizes with actin in 
animals exposed to the combined insult (Figure 8I).  Quantification of ZO-1 and actin co-
localization (Figure 8P) indicated that significantly less ZO-1 co-localized with actin in 
wild type mice exposed to ethanol and burn injury than in sham treated animals.  PIK 
treatment of wild type mice exposed to the combined insult preserved ZO-1 localization 
at the periphery of cells and its interaction with actin (Figure 8J, P). Occludin position 
can be affected by a variety of stimuli including burn injury alone, acetaldehyde (the 
predominant ethanol metabolite), TNF, and LIGHT (49, 110, 154, 179). Occludin 
localization alterations were also observed by visual examination, but this decrease in co-
localization was not as obvious as found with ZO-1 (Figure 8K-O). Quantification, 
however, of occludin and actin co-localization indicated that association of occludin and 
actin was significantly reduced in mice exposed to the burn injury alone or the combined 
insult, and this localization was re-established in mice receiving PIK after ethanol 
exposure and burn injury as compared to mice not receiving PIK treatment (Figure 8O, 
Q).  As seen at 6 hours post insult, MLCK inhibition continues to decrease intestinal 
damage and intestinal epithelial cell barrier alterations induced following ethanol 
exposure and burn injury. 
Intestinal damage and inflammation reduced following PIK treatment 
 In conjunction with a reduction in intestinal morphological damage as observed in 
Figure 8, PIK treatment also led to a 33% reduction in bacterial translocation at 24 hours 
post insult; however, this difference was not significant (Figure 9A). This reduction is  
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Figure 9: Decreased IL-6 following PIK treatment in mice exposed to ethanol and burn 
injury.  Mesenteric lymph nodes were isolated from mice sacrificed at 24 hours following 
insult (A). Lymph nodes were homogenized and plated on tryptic soy agar (TSA) plates. 
Colonies were counted the next day and normalized on the total number of lymph nodes 
removed from each mouse.  Levels presented as concentration  SEM.  *p<0.05 versus 
all other groups except burn ethanol + PIK. n = 6-8 per group. IL-6 (B) and IL-1β (C) 
levels in the ileum were measured by ELISA and normalized to total protein per sample. 
Data presented as concentration  SEM. #p<0.05 versus all other groups. n = 4-6 per 
group. 
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likely due to the decrease seen at 6 hours, but to maintain this reduction another dose of 
PIK may be needed. Although bacterial translocation was not reduced following PIK 
treatment, IL-6 levels in the ileum were significantly less in PIK-treated mice exposed to 
ethanol and burn injury as compared to mice not receiving PIK (Figure 9B).  By 24 hours 
following insult, no differences in IL-1β levels were observed between groups (Figure 
9C). As seen in Figure 8, early inhibition of MLCK alleviates intestinal damage and 
inflammation and preserves tight junctions in the intestinal epithelial barrier at 24 hours 
post combined insult.  
 These data confirm previous studies that gut inflammation is greater after ethanol 
exposure and burn injury than burn injury alone.  Furthermore, the loss or inhibition of 
MLCK promotes maintenance of intestinal epithelial tight junctions after ethanol and 
burn, thereby preventing bacterial translocation and the subsequent immune response and 
leading to less intestinal damage and inflammation. 
Summary 
 The combined insult of binge ethanol and burn injury causes systemic increases in 
TNFα and IL-6 as well as elevated inflammation, bacterial translocation, and intestinal 
permeability in the ileum. Bacterial translocation and intestinal permeability occur as a 
result of intestinal epithelial barrier damage or gaps between epithelial cells. One 
mechanism for a rise in permeability is enhanced MLCK activity. Either burn injury or 
ethanol exposure alone augments MLCK activity in intestinal epithelial cells leading to 
permeability. We hypothesized that increased MLCK activity causes intestinal epithelial 
damage and permeability in a murine model of binge ethanol and burn injury. 
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 As early as 2 hours post combined insult, both TNFα and IL-6 are elevated in the 
serum of mice exposed to ethanol and burn. By 3 hours, pMLC, a measurement of 
MLCK activity, is elevated in intestinal epithelial cell isolated from mice exposed to the 
combined insult. To investigate the role of MLCK in this model, mice were administered 
PIK, a specific inhibitor to MLCK, after ethanol and burn injury. Ethanol-exposed and 
burn-injured mice given PIK demonstrate reduced pMLC following the combined insult 
as compared similarly treated mice not receiving PIK. Shorter villi and increased 
intestinal epithelial layer damage was observed at both 6 and 24 hours following burn or 
the combined insult; however, PIK-treated animals displayed little to no alterations in 
villus morphology and barrier damage at either time point. A rise in morphological 
damage was associated with less ZO-1 and occludin localization with actin. Interestingly, 
PIK-treated mice do not demonstrate reduced villus heights or decreased ZO-1 and 
occludin localizing with actin following ethanol exposure and burn injury. Augmented 
intestinal damage after the combined insult leads to significantly enhanced bacterial 
translocation and IL-6 levels in the ileum. Animals given PIK following binge ethanol 
and burn exhibit a significant decrease in IL-6, but only a 33% reduction in bacterial 
translocation, which is not a significant change. These studies were also conducted in 
MLCK knockout mice and are described in Appendix A.   
 The combined insult of binge ethanol and burn injury amplifies MLCK activity, 
intestinal damage, and inflammation. Inhibition of MLCK alleviates these responses 
suggesting that this enzyme plays a role in ethanol and burn-induced epithelial 
permeability. 
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CHAPTER 4 
 ANTI-IL-6 ANTIBODY TREATMENT, BUT NOT IL-6 KNOCKOUT, IMPROVES 
INTESTINAL BARRIER FUNCTION AND REDUCES INFLAMMATION 
FOLLOWING BINGE ETHANOL EXPOSURE AND BURN INJURY 
Abstract 
IL-6 is an inflammatory cytokine known to be elevated in chronic diseases and 
following insults such as trauma and infection.  While necessary for the development of 
B cells and Th17 cells, IL-6, at elevated levels, can also cause tissue damage and lead to a 
rise in inflammation.  Previous work in our laboratory has shown that IL-6 is increased 
both systemically as well as in multiple organ systems including the ileum following 
ethanol exposure and burn injury.  As this combined insult causes elevated intestinal 
morphological damage, tight junction protein localization alterations, and phospho 
myosin light chain (pMLC) levels, we sought to determine the role of IL-6 in these 
intestinal responses using a model of binge ethanol exposure and burn injury.  IL-6 
antibody treatment after the combined insult reduced morphological changes in the ileum, 
bacterial translocation, and pMLC levels relative to either injury alone.  ZO-1 and 
occludin localization was also re-established in wild type mice given IL-6 antibody after 
ethanol and burn.  IL-6 knockout mice given ethanol and burn injury also had reduced 
intestinal damage; however, no changes in bacterial translocation or tight junction protein 
localization were observed as compared to similarly treated wild type mice.  These data 
suggest that IL-6 may have a role in intestinal tissue damage observed following the 
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combined insult of binge ethanol exposure and burn injury although complete loss of IL-
6 does not appear to be beneficial in this model.  Modulation of IL-6 may present a new 
option for preventing intestinal damage and associated inflammation following a 
combined insult of ethanol exposure and burn injury. 
Introduction 
 Dysfunction of the intestinal epithelial barrier occurs following numerous insults 
including infection, trauma, and disease (43, 167, 180, 181). Our laboratory and others 
have demonstrated that the combined insult of ethanol exposure and burn injury causes 
elevated intestinal inflammation, neutrophil influx, and immunosuppression of 
mesenteric lymph node T-cells (151, 182). Furthermore, this combined insult is also 
associated with elevations in intestinal permeability and bacterial translocation, decreased 
ZO-1 and occludin localization to tight junctions, and increased phospho myosin light 
chain (pMLC) (156, 183). A common molecule found in the serum as well as many 
tissues of mice exposed to ethanol and burn injury is the inflammatory cytokine, 
interleukin (IL) 6 (182, 183).   
 Important for a variety of cellular responses, IL-6 has a predominant role in the 
inflammatory response. Signaling through its receptor, IL-6R and gp130, IL-6 helps 
mediate the transition from acute to sustained inflammation (184), induces fever and 
acute phase responses following infection (185), and may contribute to tissue damage in 
states of elevated inflammation (72). Tumor necrosis factor-α (TNFα), IL-1β, 
lipopolysaccharide (LPS), and viral infections can all induce IL-6 (186-188) indicating its 
importance in the immune response. Not all cells are known to actually express IL-6Rα 
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(52); however, with the discovery of a soluble form of the IL-6 receptor (54), all cells 
expressing gp130 are able to respond to IL-6.  As most cells express gp130 on their 
surfaces, the effect of elevated IL-6 becomes global and allows for the possibility of 
tissue injury or damage in various organs of the body. 
 IL-6 has long been known as an important component of the immune response.  
Interestingly, recent work also indicates that IL-6 can also act as a causative or 
prolonging agent in disease and other cellular processes.  Obesity and insulin resistance 
(69), rheumatoid arthritis (70), aging (189) and cancer (71) all have symptoms or 
outcomes associated with elevated systemic or local levels of IL-6.  With relation to the 
gut, IL-6 provides an anti-apoptotic signal to CD4+ T cells that aggregate in 
inflammatory bowel disease allowing for further inflammation and tissue damage (73). 
Along with transforming growth factor β (TGF-β), IL-6 aids in the induction of Th17 cell 
differentiation (190).  Th17 cells produce IL-17, a known pro-inflammatory cytokine, 
which, along with IL-6, is elevated in IBD patients (72, 73). 
Following acute insults, such as injury or infectious challenge, serum levels of IL-
6 rise (181, 191). In particular, burn injury-induced mortality often correlates with 
increased IL-6 levels (192). Mouse models of burn injury indicate elevated levels of IL-6 
in the ileum (43) and when mice are exposed to a combined insult of binge ethanol and 
burn injury, IL-6 levels in the ileum are further increased (150, 182). Knockout or 
inhibition of IL-6 had previously been described as effective in the prevention of 
intestinal morphological damage and permeability in animal models of splanchnic arterial 
occlusion and reperfusion, sepsis, and hemorrhagic shock and resuscitation (193-195). 
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These data suggest that IL-6 has a role in causing or perpetuating intestinal responses 
following injury. With the knowledge that IL-6 is elevated both systemically and at the 
tissue level following exposure to either ethanol or burn injury alone as well as the 
combined insult (19, 91, 147), we sought to determine if IL-6 promotes the intestinal 
inflammation and barrier dysfunction observed after the combined insult of ethanol 
exposure and burn injury.  
Materials & Methods 
Mice 
 Wild type (C57BL/6) and IL-6 knockout (B6.129S2-7 IL6(tm1Kopf)/J) mice (6-7 
week old,) were purchased from Jackson Laboratories (Bar Harbor, ME).  Mice were 
housed in sterile microisolator cages in the Loyola University Health Sciences Division 
Comparative Medicine facility until 8-10 weeks of age (23-25 grams).  All experiments 
were conducted in accordance to National Institutes of Health guidelines and were 
approved by the Loyola Institutional Animal Care and Use Committee. 
Murine Model of Ethanol and Burn Injury 
 A murine model of a binge ethanol exposure and burn injury was performed as 
described previously (172) with minor modifications (149).  Briefly, mice were given a 
single dose of 1.11 g/kg of 20% (v/v) ethanol solution intraperitoneally that resulted in a 
blood ethanol level of 150-180 mg/dl at 30 minutes.  The mice were then anesthetized 
with 100 mg/kg of Ketamine and 10 mg/kg of Xylazine (Webster Veterinary, Sterling, 
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MA), their dorsum shaved, and placed in a plastic template exposing 15% of the total 
body surface area (TBSA) and subjected to a scald injury in 90-92° C water bath or a 
sham injury in room-temperature water.  The scald injury resulted in an insensate, full-
thickness burn injury (173).  Mice received 1 mL of saline resuscitation and their cages 
were placed on warming pads until they recovered from anesthesia.  At 30 minutes after 
burn injury, mice were given either rat IgG or rat anti mouse IL-6 antibody (i.p.) at a dose 
(eBioscience, 5 ug/mouse) previous determined in our lab (68).  This dose has previously 
been shown to restore DTH responses in our model of ethanol exposure and burn injury. 
As no differences were found between IgG and anti-IL-6 treatment in the sham groups 
and burn vehicle group, only mice given ethanol and burn injury plus anti-IL-6 are shown 
in the results section.  All other groups are treatment plus IgG. Mice were sacrificed by 
CO2 narcosis followed by cervical dislocation at 3 and 24 hours following injury. 
Histopathologic and immunofluorescent examination of the ileum 
 At the time of sacrifice, the ileum was harvested and fixed overnight in 10% 
formalin. Samples were then embedded in paraffin, sectioned at 5 microns, and stained 
with hematoxylin and eosin (H&E).  Images were taken at 200x. Immunofluorescent 
staining was done as previously described (167) with minor modifications. Briefly, a 
small section of ileum (5 mm) was embedded in OCT and frozen for immunofluorescent 
staining.  The ileum was sectioned (8 microns) and stained with either rabbit anti-ZO-1 or 
rabbit anti-occludin (Invitrogen, Carlsbad, CA) followed by goat anti-rabbit Alexa 488 
(Invitrogen, Carlsbad, CA).  Sections were further stained with fluorescent-conjugated 
phalloidin (actin) and Hoechst nuclear stain (Invitrogen, Carlsbad, CA).  Using Zeiss 
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software (Zeiss LSM 510 Version 4.2 SP1), a 20 epithelial cell section (crypt or villus) 
was outlined and only within this outlined section were the number of co-localized (both 
red and green fluorescence) pixels determined.  The number of co-localized pixels was 
divided by the total number of pixels in that section and expressed as a percentage.  This 
process was repeated an additional 4 epithelial cell sections per animal leading to 100 
total epithelial cells examined for each animal.  Results were averaged for each animal 
and this average was then used to determine the group average. 
Bacterial translocation 
 Bacterial translocation was assessed as previously described with minor 
modifications (156).  Briefly, 5-6 mesenteric lymph nodes (MLN) per mouse were 
removed, placed in cold RPMI (with 5% fetal bovine serum) and kept on ice.  Nodes 
were separated from connective tissue and homogenized in RPMI using frosted glass 
slides.  Homogenates were plated in triplicate on tryptic soy agar (TSA) plates and placed 
in a 37
o
C incubator overnight.  Colonies were counted the following day, averaged, and 
divided by the total number of lymph nodes harvested. 
Intestinal epithelial cell isolation and western blotting 
 Intestinal epithelial cells were isolated as previously described (167) with minor 
modifications.  Briefly, ileum sections were opened lengthwise, washed with calcium and 
magnesium free Hanks Basic Salt solution (HBSS), and placed in tubes containing 10 
mM DTT and phosphatase inhibitor cocktail in HBSS.  Samples were placed at 4
o
C for 
30 minutes, after which tubes were shaken briefly and ileum sections moved to tubes 
containing 1 mM EDTA and protease inhibitor cocktail in HBSS for 1 hour at 4
o
C.  After 
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incubation, tubes were shaken robustly and large pieces of tissue removed.  Samples were 
centrifuged at 1000 g for 10 minutes and the supernatant discarded.  Pelleted cells were 
lysed in 100 uL of Cell Lysis Buffer according to manufacturer’s protocol (BioRad, 
Hercules, CA). Twenty micrograms of whole cell lysate protein was boiled for 5 minutes, 
separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
transferred to polyvinylidene fluoride (PVDF) membranes and blotted with primary 
antibodies specific for phopshorylated myosin light chain (pMLC Ser19, Cell Signaling 
Technology, Danvers, MA), total MLCK (Abcam, Cambridge, MA), and villin-1 (Cell 
Signaling Technology).  
Cytokine determination in the ileum 
 Two one-inch sections of ileum were removed, luminal contents removed, and 
homogenized in 1 mL of Cell Lysis Buffer according to manufacturer’s protocol 
(BioRad, Hercules, CA).  Homogenates were then filtered and analyzed for IL-6 levels 
using ELISA (BD Biosciences, San Diego CA).  The results were normalized to total 
protein present in the homogenate using the BioRad protein assay based on the methods 
of Bradford (175) (BioRad, Hercules, CA). 
Statistical Analysis 
 Statistical comparisons (GraphPad Instat and Prism) were made between the sham 
vehicle, sham ethanol, burn vehicle, and burn ethanol treatment groups, resulting in 4 
total groups analyzed.  One-way analysis of variance was used to determine  
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differences between treatment responses, and Tukey’s post-hoc test once significance 
was achieved (p < 0.05).  Statistical comparisons made between the burn ethanol and 
burn ethanol plus anti-IL-6 treatment groups were done using student’s t-test and Tukey’s 
post-hoc test (p<0.05). Comparisons made between wild type and knockout in the same 
treatment group (i.e. burn ethanol) were done using two-way ANOVA and Bonferroni’s 
post-hoc test (p<0.05). 
Results 
Lower IL-6 levels following anti-IL-6 antibody treatment 
 Previous work from our laboratory indicates that IL-6 is increased both 
systemically and in the lung and ileum following ethanol exposure and burn injury (144, 
147, 150). Consistent with these observations, we found higher IL-6 levels in both the 
serum and ileum of mice exposed to the combined insult  and IgG (650 ± 150 pg/mL, 35 
± 5 pg/mg protein, Figure 10A, B).  However, 24 hours following IL-6 neutralizing 
antibody treatment, IL-6 was not significantly decreased in the serum or ileum (400 ± 20 
pg/mL, 20 ± 7 pg/mg protein), but this was not expected as antibody treatment was only 
administered once following insult. 
IL-6 antibody treatment reduces pMLC levels in intestinal epithelial cells 
 Our laboratory has recently described a role for myosin light chain kinase activity 
in intestinal barrier damage following ethanol exposure and burn injury (183). To 
determine if inhibition of IL-6 affects MLCK activity, we measured phosphorylation (Ser 
19) of myosin light chain (pMLC) in isolated intestinal epithelial cells. Treatment with an 
IL-6 neutralizing antibody reduced pMLC levels by nearly 70% 3 hours after exposure to  
58 
 
A
B
0
200
400
600
800
1000
Sham vehicle
+ IgG
Sham ethanol
+ IgG
Burn vehicle
+IgG
Burn ethanol
+ IgG
Burn ethanol
+ anti IL-6
IL
-6
 (
p
g
/m
L
)
0
10
20
30
40
50
Sham vehicle
+ IgG
Sham ethanol
+ IgG
Burn vehicle
+ IgG
Burn ethanol
+ IgG
Burn ethanol
+ anti IL-6
IL
-6
 (
p
g
/m
g
 p
ro
te
in
)
Serum
Ileum
*
*
 
Figure 10: IL-6 antibody treatment reduces IL-6 in serum (A) and ileum (B) following 
ethanol and burn.  Levels of IL-6 were quantified by ELISA.  Cytokine concentrations in 
ileum were normalized to total protein in the sample as determined by BioRad protein 
assay and all levels are presented as concentration  SEM. *p<0.05 versus all groups 
except antibody treated. n = 4-6 per group. 
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the combined insult as compared to mice not receiving antibody treatment after exposure 
to ethanol and burn injury (Figure 11A). At 24 hours post antibody treatment, pMLC was 
still reduced in mice exposed to the combined insult as compared to mice not receiving 
antibody; however, this difference was no longer significant (data no shown). 
Interestingly, at 24 hours post insult mice deficient in IL-6 had no change in pMLC 
following any of the treatments (Figure 11D, F). As these samples were not run on the 
same gels, no statistical analyses between wild type and IL-6 knockout mice were done. 
Due to this result and subsequent outcomes to be described in upcoming sections, 
westerns were not completed at the 3 hour time point in IL-6 deficient mice.  
Antibody treatment prevents tissue and tight junction protein alterations 
As found previously (183), mice given ethanol and burn injury had visually shorter and 
wider villi along with an elevation in intestinal epithelial cell damage as compared to 
sham treated animals (Figure 12, only burn ethanol exposed animals shown). IL-6 
knockout or wild type mice given an IL-6 neutralizing antibody had little to no intestinal 
morphological damage following exposure to the combined insult. Villi were taller and 
narrower in ethanol-exposed and burn-injured IL-6 knockout or antibody-treated wild 
type mice in contrast to burn ethanol wild type mice not treated with anti-IL-6 antibody 
(Figure 12 B, C). Greater damage to intestinal epithelial cells correlated with a reduction 
in tight junction protein co-localization with actin.  Specifically, we found that mice 
given ethanol and burn injury had a significantly less zonula occludens protein-1 (ZO-1) 
(88%, p<0.05) and occludin (83%, p<0.05) at tight junctions when compared to mice  
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Figure 11: Anti-IL-6 antibody treatment reduces pMLC (Ser19) in intestinal epithelial 
cells following ethanol exposure and burn injury. Isolated intestinal epithelial cells were 
lysed and analyzed by western blot for levels of pMLC 3 hours (A) and 24 hours (C, D) 
in IL-6 antibody-treated (A) and IL-6 knockout mice (C). Quantification of pMLC levels 
was normalized to villin-1 levels and done using BioRad Image Lab software.  Images 
are representative of 3 experiments, *p<0.05 versus antibody treated group. #p<0.05 
versus sham groups. Quantification is of n = 4-6 per group. 
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Figure 12: Treatment with anti-IL-6 preserves morphology after ethanol exposure and 
burn injury. Ileum sections from wild type, antibody-treated, and IL-6 knockout mice 
were stained with hematoxylin and eosin (A-C) and then examined for degree of 
inflammation and damage.  Representative H&E images taken at 200x.  n = 4-6 per 
group. 
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exposed to sham injury (Figure 13G).  Despite the resolution of intestinal morphological 
damage observed, IL-6 knockout mice exposed to ethanol and burn injury had similar  
localization patterns of ZO-1 as wild type mice given the combined insult (Figure 13C, 
G).  Interestingly, occludin localization was restored in ethanol-exposed and burn-injured 
knockout mice (Figure 13 C, H), but this reestablishment was not nearly as effective as 
antibody treatment.  Treatment of wild type mice given ethanol and  burn injury with an 
IL-6 neutralizing antibody promotes maintenance of ZO-1 and occludin localization with 
actin (Figure 13 B, E, G, H).  These data suggest that inhibition, but not life-long 
deficiency, of IL-6 is protective of intact tight junctions within the intestinal epithelial 
cell layer of mice exposed to ethanol and burn injury. 
Reduced bacterial translocation following antibody treatment 
Alterations in tight junction protein localization affect the integrity and function 
of the intestinal epithelial cell barrier.  As observed previously in our model (183), mice 
exposed to ethanol and burn injury have significantly greater bacterial translocation to the 
mesenteric lymph nodes (MLN) as compared to mice receiving either insult alone (Figure 
14A). Anti-IL-6 antibody treatment decreased bacterial translocation by 50% (p<0.05) 
when compared to mice not receiving antibody after the combined insult (Figure 14A). In 
contrast to antibody treated mice, knockout of IL-6 had no effect on bacteria 
accumulating in the MLN and ethanol-exposed and burn-injured knockout mice actually 
demonsrated an increase in bacterial translocation (Figure 14B).  This increase in bacteria 
in the MLN of knockout mice exposed to the combined insult is associated with a 
decrease in ZO-1 localization at tight junctions as seen in Figure 13.  These data indicate
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Figure 13: Tight junction protein localization maintained following anti-IL-6 treatment in 
combined injury animals. Frozen ileum sections were stained with antibodies against ZO-
1 (green, A-C) or occludin (green, D-F) as well as phalloidin (red) and nuclei (blue).  
Representative immunofluorescent images taken at 400x. Immunofluorescent images 
were analyzed for co-localization of ZO-1 or occludin with actin (G, H). Co-localization 
is presented as % colocalized pixels/100 epithelial cells. *p<0.05 versus wild type sham 
vehicle, sham ethanol and antibody treated groups. #p<0.05 versus wild type sham 
vehicle and sham ethanol. @p<0.05 versus knockout burn ethanol and antibody treated 
groups. n = 4-6 per group.
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that IL-6 may have a role in the intestinal epithelial damage, loss of tight junction 
integrity, and rise in bacterial translocation following ethanol exposure and burn injury; 
however, complete loss of IL-6 is perhaps more harmful than beneficial. 
Summary 
 IL-6, along with TNFα and IL-1β, are pro-inflammatory cytokines that are 
commonly up-regulated after injury, infection, and other insults. In addition to its role in 
the inflammatory response, IL-6 also aids in differentiation of some cell types and 
induces mucin production. Recent work also suggests that IL-6 can activate MLCK. 
Following binge ethanol and burn injury, MLCK activity and IL-6 were increased in the 
ileum. With this knowledge, we hypothesized that IL-6 activates MLCK and promotes 
intestinal damage, tight junction protein localization changes, and bacterial translocation 
in a mouse model of ethanol and burn injury. 
 For these studies IL-6 was inhibited with an IL-6 neutralizing antibody or IL-6 
knockout mice were used. IL-6 antibody treatment significantly decreased pMLC in 
intestinal epithelial cells at 3 hours post binge ethanol and burn injury; however, 
knockout of IL-6 had no effect on pMLC at 24 hours. (Earlier time points for western 
blots were not analyzed in IL-6 knockout mice as analyses done at the 24 hour time point 
suggest that deficiency of IL-6 may be more detrimental than beneficial to the animals in 
our model of ethanol and burn.) At 24 hours post combined insult, both inhibition and 
life-long deficiency of IL-6 lessened intestinal morphological damage when compared to 
wild type animals not receiving anti-IL-6 treatment. Only antibody treated animals 
demonstrated restored ZO-1 and occludin localization with actin following the 2 insults. 
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Figure 14: Decreased bacterial translocation to mesenteric lymph following antibody 
treatment in mice exposed to ethanol and burn injury.  Mesenteric lymph nodes were 
isolated from antibody-treated mice (A) and knockout mice (B) at 24 hours following 
insult. Lymph nodes were homogenized and plated on tryptic soy agar plates. Colonies 
were counted the next day and normalized on the total number of lymph nodes removed 
from each mouse. Levels presented as CFU/MLN  SEM.  *p<0.05 versus all other 
groups. #p<0.05 versus all other wild type groups. @p<0.05 versus all other wild type 
groups and knockout burn ethanol. n= 6-8 per group.  
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IL-6 knockout mice given ethanol and burn did have greater occludin localization 
to tight junctions than wild type mice exposed to the combined insult; however, this 
recovery was not nearly as efficient as observed with antibody treatment. In conjunction 
with the tight junction protein results, animals treated with IL-6 antibody displayed 
dampened bacterial translocation following binge ethanol and burn injury. Interestingly, 
ethanol-exposed and burn-injured IL-6 deficient mice had comparable amounts of 
bacterial translocation as similarly treated wild type mice. 
 These data suggest that anti-IL-6 antibody treatment following binge ethanol and 
burn injury reduces MLCK activity. Subsequent intestinal morphological damage and 
bacterial translocation are also diminished after the combined insult. IL-6 knockout mice 
exposed to ethanol and burn also had less intestinal damage; however, life-long 
deficiency in IL-6 does not improve intestinal barrier junctions or intestinal function after 
the dual insult. Responses observed in IL-6 knockout mice are likely due to the role of 
IL-6 in homeostatic functions or other cytokines compensating for the lack of IL-6. While 
complete loss of IL-6 does not decrease intestinal damage and inflammation following 
the combined insult, anti-IL-6 antibody treatment could possibly be used as a therapeutic 
for intestinal barrier disorders.    
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CHAPTER 5 
ROCK AND MLCP ACTIVATION ARE NOT ALTERED FOLLOWING BINGE 
ETHANOL EXPOSURE AND BURN INJURY 
Abstract 
Binge ethanol exposure or burn injury alone are known to cause intestinal tissue damage, 
permeability, and inflammation. When these insults are combined detrimental intestinal 
responses are even greater. Previous work in our laboratory indicates that myosin light 
chain kinase (MLCK) activity plays a role in intestinal damage, bacterial translocation, 
and inflammation. We wanted to determine the signaling pathway leading to elevated 
MLCK activity. One pathway involves Rho-kinase (ROCK), which is known to 
inactivate myosin phosphatase consequently leading to a rise in phospho-myosin light 
chain (pMLC). ROCK levels were not changed between groups at 90 minutes or 3 hours 
following ethanol exposure or burn injury. No alterations in ROCK corresponded with no 
changes in the phosphorylation sites (inactivation and regulatory) of myosin phosphatase. 
Furthermore, Src kinase, one activator of ROCK, activation was also not affected by the 
combined insult. These data suggest that the increase in MLCK activity observed 
following exposure to ethanol and burn injury is not due to elevated ROCK activity 
although the possibility remains that we are not examining the correct time point for this 
analysis. 
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Introduction 
 Actin reorganization is a necessary occurrence for cellular migration, 
proliferation, and general cellular function. One pathway involved in actin reorganization 
is the Rho and Rho kinase (ROCK) pathway (196). Agonists of G-coupled protein 
receptors (specifically Gq or G12/13), such as thrombin (197), lead to the activation of the 
small GTPase Rho. Once active, Rho (Rho-GTP) can then bind to the Rho-binding 
domain of ROCK thus increasing ROCK’s activity (32). Besides Rho binding, cleavage 
of ROCK’s C-terminal domain by caspase-3 leads to a constitutively active ROCK (198), 
and binding of arachidonic acid can also lead to ROCK activation (199). ROCK is a 
serine/threonine kinase (32) that can phosphorylate numerous targets including the 
myosin binding subunit of myosin phosphatase, myosin light chain (MLC), and CPI-17 
(33, 200, 201). Phosphorylation of myosin phosphatase inhibits its activity and tips the 
scale toward elevated phospho-MLC (pMLC) and actin contraction (35). A rise in pMLC 
is associated with barrier dysfunction (161), increased inflammation (202), and 
chemokine expression and leukocyte recruitment (203). 
 Following traumatic injury, like burn injury, an elevation in intestinal epithelial 
and endothelial permeability has been observed (135, 204). Increases in intestinal 
permeability are associated with greater inflammation, bacterial translocation, and tissue 
damage (205). Previous work from our laboratory and others indicates that when ethanol 
exposure is combined with burn injury, these detrimental intestinal responses are 
exacerbated (156, 183). Interestingly, elevations in intestinal epithelial cell levels of 
pMLC were also found following the combined insult (183) but no elevation in myosin 
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light chain kinase (MLCK) was observed. This suggested that the increase in pMLC may 
be due to a rise in ROCK activity and greater myosin phosphatase inactivation. 
 Activation of the ROCK pathway has been attributed to alterations in intestinal 
barrier function due to various insults. ROCK activity was recently shown to mediate 
radiation-induced intestinal barrier function (206), and endotoxin exposure led to 
decreased epithelial restitution as a result of elevated ROCK activity (207). Furthermore, 
H. pylori infection induces ROCK activity ultimately leading to disruptions in tight 
junction proteins (208). ROCK activation also contributes to leukocyte recruitment 
following intestinal ischemia/reperfusion injury (203). These studies suggest that the 
Rho/ROCK pathway plays a role in intestinal epithelial barrier homeostasis as well as 
inflammation following burn injury. Using a model of ethanol exposure and burn injury, 
we hypothesized that intestinal barrier alterations observed following the combined insult 
was due to elevated ROCK activity. 
 
Materials and Methods 
Mice 
 Wild type (C57BL/6) and IL-6 knockout male (8-10 week old, 23-25 grams) mice 
were purchased from Jackson Laboratories (Bar Harbor, ME).  Mice were housed in 
sterile microisolator cages in the Loyola University Medical Center Comparative 
Medicine facility.  All experiments were conducted in accordance with the Loyola 
Institutional Animal Care and Use Committee. 
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Murine Model of Ethanol and Burn Injury 
 A murine model of a single binge ethanol exposure and burn injury was 
performed as described previously (172) with minor modifications (149).  Briefly, mice 
were given one dose of 1.11 g/kg of 20% (v/v) ethanol solution intraperitoneally that 
resulted in a blood ethanol level of 150-180 mg/dL at 30 minutes.  The mice were then 
anesthetized with 100 mg/kg of Ketamine and 10 mg/kg of Xylazine (Webster 
Veterinary, Sterling, MA), their dorsum shaved, and placed in a plastic template exposing 
15% of the total body surface area (TBSA) and subjected to a scald injury in 90-92° C 
water bath or a sham injury in room-temperature water.  The scald injury resulted in an 
insensate, full-thickness burn injury of approximately 15% total body surface area (173).  
Mice received 1 mL of saline resuscitation and their cages were placed on warming pads 
until mice recovered from anesthesia. Animals were sacrificed by CO2 narcosis followed 
by cervical dislocation three hours following injury. 
Intestinal epithelial cell isolation and western blotting 
 Intestinal epithelial cells were isolated as previously described (167) with minor 
modifications.  Briefly, ileum sections were opened lengthwise, washed with calcium and 
magnesium free Hanks Basic Salt solution (HBSS), and placed in tubes containing 10 
mM DTT and phosphatase inhibitor cocktail in HBSS.  Samples were placed at 4
o
C for 
30 minutes, after which tubes were shaken briefly and ileum sections moved to tubes 
containing 1 mM EDTA and PIC in HBSS for 1 hour at 4
o
C.  After incubation, tubes 
were shaken robustly and large pieces of tissue removed.  Samples were centrifuged at 
1000 g for 10 minutes and the supernatant discarded.  Pelleted cells were lysed in 100 uL 
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of Cell Lysis Buffer according to manufacturer’s protocol (BioRad, Hercules, CA). 
Twenty milligrams of whole cell lysate protein was boiled for 5 minutes, separated by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to 
polyvinylidene fluoride (PVDF) membranes and blotted with primary antibodies specific 
for phosphorylated myosin light chain (pMLC Ser19, Cell Signaling Technology, 
Danvers, MA), ROCK1 (Cell Signaling Technolgoy), phosphorylated myosin 
phosphatase (Thr696 and Thr850, Millipore, Danvers, MA) and villin-1 (Cell Signaling 
Technology). 
Statistics 
 Statistical comparisons (GraphPad Instat and Prism) were made between the sham 
vehicle, sham ethanol, burn vehicle, and burn ethanol treatment groups, resulting in 4 
total groups analyzed.  One-way analysis of variance was used to determine differences 
between treatment responses, and Tukey’s post-hoc test once significance was achieved 
(p < 0.05).  
Results 
 Recent work from our laboratory indicates that the dual insult of binge ethanol 
and burn injury leads to a significant elevation in pMLC in intestinal epithelial cells 
(183); however, no elevation in MLCK was observed.  We sought to determine whether 
this rise in pMLC was due to ROCK-induced phospho-myosin phosphatase (pMLCP) 
inactivation. 
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No changes in ROCK levels following ethanol and burn 
 As the earliest increase in pMLC was observed at 3 hours following the combined 
insult, we examined intestinal epithelial cell levels of ROCK at both 90 minutes and 3 
hours after ethanol and burn injury. Surprisingly, no changes in ROCK were observed 
between groups at either time point (Figure 15A, B). As no differences between groups 
were found at the 3 hour time point, only the sham vehicle and burn ethanol groups were 
employed at the 90 minute time point. 
Inhibitory and regulatory MLCP phosphorylation sites not altered by combined insult 
 Although ROCK did not appear to be altered following exposure to ethanol and 
burn injury, we analyzed the phosphorylation status of the inactivation site (Thr696) and 
regulatory site (Thr850) on MLCP. ROCK can phosphorylate both sites (36, 37). Neither 
Thr696 nor Thr850 phosphorylation were changed by ethanol exposure, burn injury, or 
the combined insult (Figure 16 A, C). 
Activators of ROCK not altered following combined insult 
 Besides the binding of Rho, other factors are known to enhance ROCK activity. 
Both IL-1β and IL-6 have been shown to active the Rho signaling pathway ultimately 
leading to ROCK activation (208, 209). While IL-1β and IL-6 are both elevated in the 
ileum at varying time points, 6 and 24 hours respectively, serum levels of IL-6 are 
increased by 2 hours post insult (183). The work of Lin and colleagues indicates that IL-6 
induces ROCK via Src (209); however, we found no differences in levels of active Src at 
3 hours post insult (Figure 17A). Interestingly, it appears that mice exposed to burn injury 
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Figure 15: ROCK levels not altered following ethanol exposure and burn injury. Isolated 
intestinal epithelial cells were lysed and analyzed by western blot for levels of ROCK 
either 90 minutes (A) or 3 hours (B) after exposure to treatment. Quantification of ROCK 
levels was normalized to villin-1 levels and done using BioRad Image Lab software.  
Images are representative of 3 experiments. Quantification is of n = 4-6 per group. 
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or the combined insult had less active Src than sham-injured mice, but this change was 
not significant.  
 Overall, these data reveal that there is no significant increase in ROCK pathway 
activity following ethanol exposure and burn injury. Although we observed an increase in 
pMLC in IECs, neither inhibition of MLCP or direct phosphorylation by ROCK appear to 
be responsible for this effect. 
Summary 
 We previously described a role for MLCK in intestinal damage, permeability, and 
tight junction protein localization in a murine model of binge ethanol and burn injury. 
Furthermore, IL-6 signaling also contributes to MLCK activity as inhibition of IL-6 
reduced pMLC in animals exposed to the combined insult. Neither of these observations, 
however, detail a mechanism leading to MLCK activation. Here, we examined the 
activation of ROCK, MLCP, and Src kinase in intestinal epithelial cells isolated from 
mice exposed to binge ethanol and burn injury. 
 At 90 minutes and 3 hours post combined insult, no differences in ROCK were 
discovered between groups. ROCK phosphorylates (and inactivates) MLCP at both 
threonine 696 and threonine 850, but pMLCP (Thr696 andThr850) were not altered at 3 
hours following binge ethanol and burn. Finally, Src kinase can phosphorylate MLCK 
causing enhanced MLCK activity. Despite an observed increase in pMLC at 3 hours post 
combined insult, Src kinase (pTyr416) levels were not different between groups. 
 These data suggest that the combined insult of binge ethanol and burn injury do 
not cause a significant elevation in the activity of the ROCK pathway. This does not 
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Figure 16: Combined insult does not change regulatory of inhibitory phosphorylation 
levels of myosin phosphatase at 3 hours after ethanol and burn. Isolated intestinal 
epithelial cells were lysed and analyzed by western blot for levels of pMLCP at either 
Thr696 (A) or Thr850 (C) after exposure to treatment. Quantification (B, D) of pMLCP 
levels was normalized to villin-1 levels and done using BioRad Image Lab software.  
Images are representative of 3 experiments. Quantification is of n = 4-6 per group. 
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Figure 17: Src kinase activation not increased at 3 hours following ethanol and burn 
injury. Isolated intestinal epithelial cells were lysed and analyzed by western blot for 
levels of pSrc kinase (A) after exposure to treatment. Quantification (B) of pMLCP levels 
was normalized to villin-1 levels and done using BioRad Image Lab software.  Images 
are representative of 2 experiments. Quantification is of n = 4-6 per group. 
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insinuate that ROCK has no influence on MLCK activation. MLCP is phosphorylated 
indicating that ROCK is active. It is possible that a significant rise in ROCK and pMLCP 
(inactive) is not necessary for the elevation in MLCK activity observed after binge 
ethanol and burn injury. 
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CHAPTER 6 
DISCUSSION 
 In review, we used a mouse model of ethanol exposure and burn injury to 
investigate the role of MLCK in intestinal permeability and inflammation. Previous 
studies in a rodent model have shown that binge ethanol exposure and burn injury can 
cause intestinal permeability and bacterial translocation (63, 155); however, the possible 
mechanism of these changes has not been determined.  The results described in the 
present study indicate that after the combined insult of ethanol exposure and burn injury 
MLCK contributes to alterations in tight junction localization, bacterial translocation, 
along with intestinal inflammation and damage (Figures 8, 9, Table 1).  PIK-treated mice 
had a reduction in these parameters including less villus blunting, edema, destruction of 
the intestinal epithelial layer, and tight junction protein localization alterations as 
compared to similarly treated wild type mice not receiving PIK (Figure 8).  Although 
MLCK is an enzyme necessary for epithelial barrier maintenance, inhibition of MLCK 
could be beneficial for decreasing intestinal morphological damage and inflammation 
following ethanol and burn injury. This decline in morphological damage corresponded 
with reduced ileum IL-6 levels in PIK-treated mice (Figure 9).  While PIK-treated mice 
did not have significantly lower bacterial translocation 24 hours after the combined 
insult, it was 33% less than ethanol-exposed and burn-injured mice not given PIK.  It is 
likely that more than one PIK administration would be necessary to significantly reduce 
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2 hour 3 hour 6 hour 24 hour 48 hour 72 hour
Response 
following 
ethanol and 
burn
- No changes 
in cytokine
levels in 
ileum
- ↑ pMLC in 
IEC
- No changes 
in MLCK, 
MLCP, or 
ROCK
- ↑ pMLC in 
IEC
- ↑ IL-6 and 
IL-1β in ileum
- ↑ bacterial 
translocation
- No changes 
in TJ protein 
localization
- ↓ villus height
- ↑ villus edema
- ↑ ileum IL-6
- ↑ ileum tissue 
damage
- ↓ ZO-1 and 
occludin at tight 
junctions
- Bacterial 
translocation 
still elevated
- Villi still 
shorter in burn
ethanol group
- Villus 
morphology
return to 
normal
- Cytokine 
levels return to 
baseline
 
Table 1: Summary of ethanol exposure and burn injury-induced responses in ileum in 
first 72 hours post insult. The combined insult of binge ethanol exposure and burn injury 
causes intestinal damage, inflammation, and barrier dysfunction, .This table summarizes 
the events occurring in ileum at the designated time points, starting at 2 hours and ending 
at 72 hours.   
81 
 
bacterial translocation at later time points, which is an ongoing study in our laboratory.  
Studies examining immune cell function suggest that bacterial accumulation in the MLN 
occurs in a model of ethanol exposure and burn injury, likely due to decreased T cell 
proliferation and reduced production of IL-2 and interferon-γ (63, 155). Moreover, 
previous work in our model indicates an increase in ileum levels of IL-10 at 24 hours post 
combined insult (147). Overall these data suggest that the combination of ethanol 
exposure and burn injury not only affect barrier permeability but also delay resolution of 
bacteria in the MLN allowing for bacterial accumulation and the possibility of bacterial 
dissemination.  
Alterations in intestinal permeability have long been studied as the cause or 
outcome of numerous diseases and injuries.  Common in chronic inflammatory disorders, 
such as inflammatory bowel syndrome, elevated intestinal barrier dysfunction may 
contribute to progression of the disease due to a continuous immune response (210).  Pro-
inflammatory mediators, particularly TNFα, LIGHT (a member of the TNF 
superfamily), IL-1β, and IL-6 have all been shown to increase intestinal permeability in 
animal models of hemorrhagic shock and resuscitation, diarrhea and epithelial barrier 
dysfunction (49, 193, 211).  Of these cytokines, most studies have focused on TNFα in 
barrier dysfunction.  TNFα was shown to directly up-regulate MLCK transcription as 
well as protein levels (48, 163) and the cytokine also promotes occludin internalization 
(49, 212).  In models of inflammatory bowel disease, antagonism of TNFα resulted in 
partial restoration of T-cell mediated barrier dysfunction (167); however, in our model of 
binge ethanol exposure and burn injury, we only see an early rise in serum levels of 
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TNFα.  This initial rise in TNFα suggests that it could still be an activator of MLCK as 
our elevation in MLCK and pMLC are observed early after the insult as well.  
Furthermore, TNFα is also known to increase levels of other pro-inflammatory cytokines, 
such as IL-1β and IL-6, which may be important regulators of the alterations seen in the 
intestine after exposure to the combined insult.  In line with this thought, we observed an 
increase in ileum levels of IL-1β at 6 hours and IL-6 at 24 hours following the combined 
insult (Figures 7 and 9). Interestingly, IL-6 was also elevated in the serum at 2 hours post 
combined insult and previous work indicates that it remains elevated until at least 24 
hours (68). Taken together, these data indicate that both TNFα and IL-6 may have a role 
in activation of the MLCK pathway and later tissue damage, inflammation, and 
alterations in the intestinal barrier.    
 Our studies support previous work that ethanol exposure combined with burn 
injury causes additive damage on intestinal barrier dysfunction than burn injury or 
ethanol exposure alone. Choudhry and colleagues have shown greater bacterial 
translocation to the mesenteric lymph nodes in a rat model of ethanol exposure and burn 
injury (155, 156).  This correlated with increased in vivo gut permeability and bacterial 
overgrowth, but not with changes in intestinal morphology.  Furthermore, intestinal 
edema and MPO were higher in mice exposed to the combined insult than in mice given 
either injury alone (151).  Neutrophil depletion or anti-IL-18 antibody treatment reduced 
ileum neutrophil infiltration and MPO levels in the same model (151, 152).  The findings 
presented in this study are similar to those previously published by our group and others 
despite using a slightly different model.  We do, however, find greater intestinal 
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morphological damage than was observed seen in other models of ethanol exposure and 
burn injury.  This difference in intestinal damage might be attributed to subtle differences 
in ethanol administration, timing of administration relative to injury, peak blood alcohol 
level or small variations in burn injury protocol; however, both models produce 
elevations in inflammation and barrier dysfunction. 
 Unlike previous studies, data presented here show, for the first time, a possible 
mechanism, which could explain how the previously reported marked elevation in 
systemic and local levels of cytokine might trigger the observed increase in intestinal 
damage after exposure to ethanol and burn injury (Figure 5-9, 18-20).  While MLCK has 
been extensively studied in chronic inflammatory diseases, the role of this enzyme after a 
combined insult or other acute insults has not been as well defined.  Using a MLCK 
inhibitor, we have demonstrated that MLCK functions in tight junction protein 
localization and subsequent bacterial translocation and inflammation in a model of 
ethanol exposure and burn injury.  The mechanism of this restoration is currently being 
studied with several possible pathways being involved.  MLCK activation is highly 
correlated with TNFα and while we do not see changes in TNFα in the ileum after insult, 
it may very well be the predominant signal for MLCK activation.  TNF signaling causes 
increases in both expression and protein levels of IL-6 (213) and MLCK (163) and can 
also activate numerous kinase cascades, which could easily lead to MLCK activation.  
Multiple pathways may converge leading to the damage and alterations seen in the ileum 
after the combined insult.  
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Figure 18 continued on next page.
85 
 
IL-6
TNFα IL-6
TNFα
MLC
K
MLC
K
MLC
K
MLC
K
MLC MLC MLC MLC
IL-6
IL-6
TNFα
Lumen
Lamina 
propria
capillary
lymphatic
Mesenteric 
lymph node
TJ
AJ
D
B
 
 
Figure 18: Serum levels of IL-6 and TNFα elevated 2 hours after combined insult. The 
intestinal epithelial layer is composed of many cells types held together by a variety of 
junction complexes (A) If we look closer at this barrier (B), we see that these complexes 
consist of tight junctions (TJ, purple boxes), adherens junctions (AJ, green boxes), and 
desmosomes (D, grey boxes). Early (2 hours) after binge ethanol and burn injury, an 
elevation in pro-inflammatory cytokines can be observed in the blood of exposed 
animals.  
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Figure 19: MLCK activation is associated with an elevation in inflammation, tissue 
damage, and tight junction protein localization changes at 24 hours post combined insult. 
MLCK activity promotes intestinal barrier damage, inflammation, and alterations in tight 
junction protein localization. By 3 hours post combined insult, an elevation in pMLC is 
observed. This is followed be decreased tight junction integrity and a rise in epithelial 
cell damage, bacterial translocation and ileum levels of IL-6.  
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Figure 20: Inhibition of MLCK or IL-6 reduces detrimental intestinal responses following 
binge ethanol and burn injury. Inhibition of MLCK or IL-6 reduces pMLC in intestinal 
epithelial cells and is associated with decreased intestinal epithelial cell damage, bacterial 
translocation, inflammation, and tight junction protein localization alterations. 
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 In summary, the results of Chapter 3 indicate that inhibition of MLCK is 
beneficial for the reduction of intestinal damage, barrier leakiness, and inflammation after 
exposure to ethanol and burn injury.  As previously stated, MODS and MOF are the most 
common outcomes of burn injury (158, 159). Recent clinical studies indicate that trauma-
induced sepsis patients with a history of alcohol abuse have an increased risk of acute 
respiratory distress syndrome (ARDS), the first stage of MODS. (214). Interestingly, 
preliminary work in our laboratory suggests that PIK treatment also reduces the 
neutrophil chemokine, KC, in the lung as well as the total number of neutrophils 
infiltrating into the lung following ethanol exposure and burn injury. Furthermore, studies 
conducted in Loyola’s Burn ICU demonstrate that intoxicated patients who suffer burn 
injuries have smaller burns than non-drinking burn patients, but spend the same number 
of days in the hospital, have as many days on the ventilator and accrue the same amount 
of hospital costs as non-drinking patients with much larger burns (143).  Thus, 
intoxicated patients with minor burn injuries suffer more complications than their not 
drinking counterparts. Data presented here implicate that patients who suffer a burn 
injury with ethanol in their system may have impaired intestinal barrier function thus 
contributing to an elevated state of inflammation and perhaps severe downstream 
complications. Overall, these data associate MLCK in the pathogenesis of binge ethanol 
and burn-induced intestinal barrier dysfunction and elevated intestinal inflammation and 
suggest a possible role for MLCK in other acute gastrointestinal injuries. 
 MLCK activity is regulated by various factors, including inflammatory cytokines. 
IL-6 is a multi-functional cytokine capable of promoting both beneficial and detrimental 
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outcomes depending on the level of IL-6.  At elevated levels, as seen in inflammatory 
bowel disease and rheumatoid arthritis, IL-6 is known to perpetuate the inflammatory 
state and tissue destruction of these diseases partially through the induction of Th17 cells 
(215, 216).  Previous work indicates that increased systemic IL-6 observed following 
sepsis and burn injury leads to cellular immunosuppression (65, 66) and our laboratory 
has demonstrated that ethanol exposure combined with burn injury causes even further 
cellular immunosuppression thus allowing for increased susceptibility to infection (68, 
144). A minimal amount of IL-6 is required for normal cellular functions like the 
development of B and Th17 cells (58, 190); however, it is the sustained elevation in 
systemic and tissue levels of IL-6 that can cause tissue injury, increased inflammation, 
and delayed resolution of the immune response following insult (43, 72, 181, 192).  In the 
gut, intestinal epithelial cells have been shown to produce IL-6 in response to cytokine 
and TLR4 signaling induced by infection, disease, or injury (186-188). As seen in Figure 
10, the combined insult of ethanol exposure and burn injury leads to significant increase 
in both serum and ileum levels of IL-6.  IL-6 has been associated with permeability in 
models of ethanol exposure or burn injury alone (43, 217). Other studies indicate that 
elevations in IL-6 are linked to mucosal permeability in both rodents and humans (218, 
219). Additionally, using Caco-2 cells as a model of the intestinal epithelial cell barrier, 
work by Suzuki and colleagues suggests that IL-6 increases tight junction permeability 
via an increase in expression of the leaky tight junction protein, claudin-2 (74). 
Combined these studies indicate the importance of controlled IL-6 signaling in the 
intestine both in a healthy individual and following insult.  
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The role of IL-6 in tissue injury is dependent on the type of injury, the specific 
tissue, and the level of IL-6.  IL-6 treatment was found to be protective of 
ischemia/reperfusion injury in a fatty liver (220) and in ethanol-induced hepatocyte 
oxidative stress and mitochondrial dysfunction (221). Interestingly, IL-6 has also been 
described to up-regulate keratins in the intestinal epithelial cell barrier in a dodecyl 
sodium sulfate (DSS)-induced barrier dysfunction model (222). This up-regulation of 
keratins protected barrier function suggesting that in situations of intestinal barrier 
compromise, IL-6 may be necessary for maintenance of the intestinal epithelial cells 
(222).  The work of Wang et al. may provide a possible explanation for why our IL-6 
knockout mice exposed to ethanol and burn had patterns of localization similar to 
comparably treated wild type mice (Figure 13).   
In contrast to the above studies, IL-6 has also been shown to be necessary for 
intestinal barrier dysfunction in a model of hemorrhagic shock and resuscitation (193). 
Knockout of IL-6 led to decreased intestinal permeability following induction of sepsis 
(194) and reduced ileal morphological injury, neutrophil infiltration into the intestine and 
serum levels of pro-inflammatory cytokines in a model of splanchnic artery occlusion 
(195). Interestingly, data presented in Chapter 4 suggest that knockout of IL-6 is not 
protective of intestinal barrier function but does prevent morphological damage induced 
by the combined insult of ethanol exposure and burn injury (Figures 12 and 14).  IL-6 
knockout mice subjected to hind limb ischemia or hemorrhage also did not have a 
reduction in bacterial translocation (223), further indicative that IL-6 may play different 
roles in tissue inflammation and injury depending on the nature of the insult. Moreover, 
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as is true in many knockout strains, a compensatory response may have been activated 
thus producing responses observed following ethanol exposure and burn injury. Whether 
that compensatory response occurred in our model is not known, but increased activity of 
other members of the IL-6 family or other pro-inflammatory pathways may have 
produced the responses we discovered in the IL-6 knockout mice. 
IL-6 signaling causes numerous responses depending on the cell type.  Known to 
signal through signal transducer and activator of transcription 3 (Stat3) and induce 
transcription of genes (224), stimulation through IL-6 also leads to activation of the 
phosphatidyl-inositol 3 kinase (PI3K)/Akt pathway (225).  Signaling through the 
PI3K/Akt pathway is usually associated with being anti-apoptotic (226). Furthermore, IL-
6 activation induces the mitogen activated protein kinase (MAPK) cascade (227), 
specifically ERK1/2 (extracellular signal-related kinase), a pathway associated with cell 
survival.  While numerous stimuli activate the MAPK and PI3K/Akt pathways (228, 229) 
IL-6 deficiency may be a compounding factor in detrimental intestinal responses 
observed following ethanol exposure and burn injury.  Grivennikov and colleagues found 
decreased intestinal epithelial cell survival and crypt cell proliferation in dextran sodium 
sulfate (DSS)-treated IL-6 knockout mice as compared to similarly treated wild type mice 
(230).  This further supports the idea that IL-6 is important for IEC survival and 
maintenance in time of injury.  
Tight junction proteins are often disrupted in the intestinal barrier following many 
insults including trauma, disease, and infection (180, 231, 232). These insults also lead to 
elevated IL-6 levels (72, 147, 233); however, the majority of studies have examined other 
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cytokines, such as TNFα and IL-1β, in tight junction protein regulation.  IL-6 treatment 
of HUVECs (human umbilical vein endothelial cells) led to an elevation in monolayer 
permeability and alterations in ZO-1 localization. Using a PKCα (protein kinase C) and 
PKCβ inhibitor in conjunction with an IL-6 antibody partially restored barrier function of 
the HUVECs (234). This result is similar to our ethanol-exposed and burn-injured mice 
given an IL-6 antibody (Figures 13 and 14); however, when no IL-6 was present the 
therapeutic effect was lost suggesting that some IL-6 is necessary for proper tight 
junctions in the IEC barrier. In a model of reflux esophagitis, Li and colleagues found 
that IL-6 was elevated in infiltrating inflammatory cells (235). This elevation in IL-6 
corresponded with a rise in claudin-1, occludin and ZO-1 in surrounding epithelial cells; 
however, newly synthesized tight junction proteins failed to organize at the plasma 
membrane.  Furthermore, production of junction proteins was not enough to repair 
lesions induced in the model. Whether IL-6 affects tight junction protein localization 
directly or indirectly is not clear from these studies, but it does insinuate that IL-6 has an 
effect on tight junction protein production and possibly localization. 
Pro-inflammatory cytokines, in particular TNFα, have been shown to induce 
barrier dysfunction in models of IBD as well as traumatic injury (43, 210, 236). TNFα, as 
well as IL-1β and LIGHT, are known enhancers of MLCK transcription and activation 
(42, 49, 163).  Interestingly, we found that anti-IL-6 antibody treatment led to less pMLC 
(Figure 11) following ethanol exposure and burn injury. Few other studies have examined 
IL-6’s role in MLCK signaling, but Suzuki et al. discovered that IL-6 treatment had no 
effect on pMLC in a Caco-2 cell culture model (74) although barrier function of this 
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monolayer was decreased.  While this would advocate for IL-6-induced barrier function 
not being MLCK-dependent, this work was done in cell culture indicating that other cells 
may be necessary for an effect.  Current research in our laboratory is examining whether 
IL-6 does have a direct effect on MLCK activity.  Preliminary experiments will examine 
changes in Src kinase activation, an enzyme downstream of IL-6 signaling and known to 
enhance MLCK activity (41).   
Our data indicate that an elevation in serum and ileum levels of IL-6 may have a 
role in intestinal epithelial cell barrier alterations following ethanol exposure and burn 
injury.  When IL-6 was inhibited with a neutralizing antibody bacterial translocation was 
reduced and greater ZO-1 and occludin localized to the tight junction.  These results were 
accompanied by reduced pMLC in intestinal epithelial cells (Figures 11-14, 18-20).  
While complete knockout of IL-6 did not appear to be beneficial for intestinal responses 
following the combined insult, some reduction in IL-6 may present a new option for aid 
in models of intestinal barrier dysfunction. 
In addition to inflammatory stimulation, MLCK’s activity is affected by proteins 
such as ROCK, MLCP, and Src kinase. Activation of the ROCK pathway is known to 
cause numerous effects including cellular contraction, proliferation, mobility, and 
apoptosis (237). ROCK has also been shown to play a role in inflammation and tissue 
damage following infection (208), radiation (206), endotoxin exposure (207), and 
ischemia-reperfusion injury (203). In our model of ethanol exposure and burn injury, we 
hypothesized that ROCK may be inducing the up-regulation of pMLC in intestinal 
epithelial cells thus causing downstream barrier dysfunction and inflammation. Despite 
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ROCK’s involvement in the MLCK pathway, its levels are not greater in IECs of mice 
exposed to ethanol and burn injury (Figure 15). This is associated with no alterations in 
MLCP phosphorylation (Figure 16) and no changes in the ROCK activator, Src (Figure 
17). These data suggest that ROCK activity is not elevated following exposure to ethanol 
and burn injury; however, it does not mean that ROCK is not functioning in responses 
observed in the intestine after the combined insult. We examined ROCK at 90 minutes 
post insult, but the possibility remains that we need to analyze an even earlier time point 
such as 30 minutes. Moreover, little to no information exists on the effect of ethanol or 
burn injury on ROCK. Boe and colleagues have described a role for a single dose of 
ethanol on an increase in ROCK activity, but the ethanol dose used in these studies was 3 
times higher than used in our work and done entirely in vitro (238). Comparing in vivo 
and in vitro studies is challenging, but the 50-100 mM ethanol doses used in this paper 
are equivalent to approximately 400 mg/dL and higher in vivo. This level is 5 times the 
legal limit and is not physiologic so direct comparisons between our studies should be 
limited. As our model does not cause as severe an inflammatory response as previous 
work (209, 239), this may explain why we do not observe an elevation in ROCK activity.  
 Other proteins are capable of inhibiting the ROCK/MLCP pathway that may be 
up-regulated following the combined insult of ethanol exposure and burn injury. While 
RhoA, B, and C are activators when bound to ROCK, RhoE inhibits ROCK activity when 
bound (196, 240). RhoE levels are not known following exposure to ethanol and burn 
injury. Besides ROCK phosphorylation, MLCP can also be inhibited by the binding of 
CPI-17. CPI-17, when phosphorylated by PKC, binds to MLCP and prevents it from de-
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phosphorylating MLC (38). CPI-17 is currently not known to be expressed in intestinal 
epithelial cells, but it is expressed in smooth muscle (38). Although smooth muscle is a 
large component of the intestine, it is not near the epithelium and CPI-17 is not known to 
be excreted. This would suggest that CPI-17 does not have a role in MLCP inhibition in 
isolated intestinal epithelial cells. Recent studies indicate that ROCK activates IκB 
kinase, which activates the NF-κB pathway (202). NF-κB is the predominant 
transcription factor for many inflammatory proteins including TNFα and IL-6 (241). The 
work of Segain and colleagues indicates that ROCK’s role in our model of ethanol 
exposure and burn injury may be in the early induction of inflammation although with no 
measureable increase in ROCK, this does not appear to be a likely occurrence. Data 
presented here suggest that the combined insult of ethanol exposure and burn injury does 
not elevate ROCK pathway activity, but it does not rule out the chance of ROCK having 
a role in intestinal responses following the dual insult. Tissue damage, neutrophil 
infiltration, or cytokine levels are not increased to the extent as others in the literature 
(202, 203, 206, 208) which could explain why no significant increases in ROCK were 
found.  
 Two other enzymes are known to phosphorylate MLC in addition to MLCK and 
ROCK, integrin-linked kinase (ILK) and zipper-interacting protein kinase (ZPK) (248, 
249). Little information exists about these kinases in intestinal epithelial cells; however, a 
role for ILK was discovered in intestinal epithelial restitution (249).  Currently, it is not 
known whether ZPK is expressed in intestinal epithelial cells, but both ILK and ZPK 
represent other possible pathways to investigate as an explanation of our pMLC results.  
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 Overall, data described here indicate that following ethanol exposure and burn 
injury, MLCK activity rises in intestinal epithelial cells. Elevated MLCK activity, as 
measured by pMLC levels, is linked with enhanced bacterial translocation and ileum IL-6 
amounts (Figure 18-21, Table 1). Furthermore, ZO-1 and occludin localization to tight 
junctions is decreased following the combined insult. Inhibition of MLCK using the 
specific inhibitor PIK, or inhibition of IL-6 using a neutralizing antibody diminishes 
MLCK activity, intestinal inflammation, and bacterial translocation (Figure 18). Both 
inhibition of MLCK or IL-6 also restored tight junction protein localization. Surprisingly, 
none of the other proteins involved in the MLCK pathway (ROCK, MLCP) are altered in 
levels or activity after ethanol exposure and burn injury. 
 Clinical studies suggest that burn patients and alcoholics suffer from 
gastrointestinal problems such as permeability and inflammation. Moreover, these 
patients also have an increased susceptibility to infection. The intestine is a large 
reservoir of bacteria that in healthy individuals causes no troubles, but if the intestinal 
barrier is compromised, these bacteria can enter the intestinal tissue and perhaps lead to a 
systemic infection. Although medical treatment has gotten better at preventing infections 
in hospitalized patients, the source of bacteria may also come from within the patient. In 
other words, if the intestinal barrier breaks down, a patient’s own bacteria can cause 
harm. All of these clinical data indicate that prevention of intestinal barrier damage and 
permeability could thwart further systemic complications, such as lung infection (Figure 
19). As MLCK’s predominant function is maintenance of the epithelial barrier and its  
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Figure 21: Proposed model of binge ethanol and burn-induced intestinal damage, 
inflammation, and possible systemic consequences. The combined insult causes elevated 
serum and ileum levels of pro-inflammatory cytokines leading to MLCK activation and 
phosphorylation of MLC. Increased MLCK activity triggers intestinal tissue damage and 
bacterial translocation, which can further augment inflammation in the ileum and other 
organs, such as the lung.  
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activation is commonly augmented following injury and ethanol exposure, it represents a 
possible target to better treat ethanol-exposed and burn-injured patients. 
  
 [99] 
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APPENDIX A 
MLCK KNOCKOUT MICE DISPLAY REDUCED INTESTINAL EPITHELIAL 
BARRIER DYSFUNCTION AND INFLAMMATION FOLLOWING BINGE 
ETHANOL AND BURN INJURY 
Results 
 Previous data described in Chapter 3 indicate that inhibition of MLCK reduces 
intestinal damage, tight junction protein position alterations, bacterial translocation, and 
ileum inflammation. Similar studies were conducted in MLCK knockout mice, which 
lack only the long form of the enzyme. 
Elevation in pMLC despite knockout of MLCK following binge ethanol and burn 
 An increase in pMLC was previously described at 3 hours after binge ethanol and 
burn injury (Figure 6). Inhibition of MLCK using PIK significantly reduced pMLC 
following the combined insult (Figure 6). Surprisingly, MLCK knockout mice do not 
display less pMLC following ethanol exposure and burn injury (Figure 22). In fact, 
pMLC levels are significantly higher in MLCK knockout mice exposed to the combined 
insult as compared to comparably exposed wild type mice. A similar finding was 
observed in the burn injury alone group as well (only densitometry shown, Figure 22). 
Further studies need to be conducted to determine if other kinases, such as ROCK, are 
responsible for the elevated phosphorylation of MLC in the absence of MLCK. 
Knockout of the MLCK gene alleviates morphological damage after combined insult 
 Twenty-four hours following the combined insult, villi of MLCK knockout mice 
(Figure 23) exposed to burn injury alone (data not shown) or ethanol plus burn injury 
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Figure 22: pMLC not decreased in MLCK knockout mice following burn injury or binge 
ethanol and burn injury. Isolated intestinal epithelial cells were lysed and analyzed by 
western blot for levels of pMLC at serine 19 in wild type and MLCK knockout mice 
exposed to binge ethanol and burn injury. Quantification of pMLC levels was normalized 
to villin-1 levels and done using BioRad Image Lab software.  Images are representative 
of 2 experiments.*p<0.05 versus both sham vehicle groups and comparably treated wild 
type group. Quantification is of n = 3-6 per group. 
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were comparable to sham treated animals (Figure 8) with tall (179 µm ± 16), narrow villi. 
Furthermore, no indications of intestinal epithelial barrier damage are observed in 
histological samples from MLCK knockout mice exposed to binge ethanol and burn.    
   Unlike wild type mice, neither burn alone nor the combined insult affected ZO-1 
localization in MLCK  knockout mice.  All MLCK knockout treatment groups (only burn 
ethanol shown) had high levels of ZO-1 and actin co-localization (Figure 23 D, G).  As 
described previously, quantification of ZO-1 and actin co-localization (Figure 8) 
indicated that significantly less ZO-1 co-localized with actin in wild type mice exposed to 
ethanol and burn injury than in sham treated animals.  MLCK knockout mice given the 
combined insult had greater ZO-1 co-localization than their wild type counterparts and all 
MLCK knockout treatment groups had statistically greater co-localization than ethanol-
exposed and burn-injured wild type mice (p<0.05). While MLCK knockout mice exposed 
to ethanol and burn injury did not have occludin co-localization that were restored to 
sham levels, it was significantly elevated (p<0.05) as compared to similarly treated wild 
type mice (p<0.05, Figure 23 F, H).   
Decreased MLCK activity reduces epithelial damage and inflammation  
after combined insult 
Using bacterial translocation as a measure of epithelial damage, we again saw that wild 
type mice exposed to the combined insult had greater bacteria accumulation in the 
mesenteric lymph nodes than in mice exposed to either injury alone.  In contrast, MLCK 
knockout mice did not have elevated levels of bacteria in the MLN after ethanol and burn 
injury (Figure 24).  These results correspond with findings from PIK treatment and 
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Figure 23: Reduced intestinal damage and tight junction protein localization change in 
MLCK knockout mice 24 hours after ethanol and burn.  Ileum sections from wild type 
mice were stained with hematoxylin and eosin (A, B) and then examined for degree of 
inflammation and damage.  Representative H&E images taken at 200x.  Frozen ileum 
sections were stained with antibodies against ZO-1 (green, C, D) or occludin (green, E, F) 
as well as phalloidin (red) and nuclei (blue).  Representative immunofluorescent images 
taken at 400x. Co-localization is presented as % colocalized pixels/100 epithelial cells. 
*p<0.05 versus wild type sham vehicle and sham ethanol, #p<0.05 versus comparably 
treated knockout group.  n = 6-8 per group. 
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Figure 24: Decreased bacterial translocation and ileum levels of IL-6 in MLCK knockout 
mice exposed to ethanol and burn injury.  Mesenteric lymph nodes were homogenized 
and plated on tryptic soy agar (TSA) plates from MLCK knockout and wild type mice 
(A) 24 hours after insult.  Colonies were counted the next day and normalized on the total 
number of lymph nodes removed from each mouse.  Levels presented as concentration  
SEM.  Levels of IL-6 were quantified in MLCK knockout and wild type mice by ELISA 
(B).  Cytokine concentrations were normalized to total protein in the sample as 
determined by BioRad protein assay and presented as concentration  SEM. *p<0.05 
versus all other wild type groups, #p<0.05 versus comparably treated knockout group. n 
= 3-6 per group. 
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indicate that MLCK promotes barrier damage and bacterial translocation in a model of 
binge ethanol and burn injury. 
 With the knowledge that ethanol and burn injury incur greater morphological 
damage and bacterial translocation than either insult alone, we examined the effect of 
MLCK deficiency on inflammatory cytokines.  As observed previously, there was a 33% 
increase in ileal IL-6 as compared to burn injury alone (Figure 9).  Unlike wild type mice, 
the ileum IL-6 levels in all MLCK knockout groups were significantly lower than wild 
type mice given ethanol and burn injury (Figure 24).  IL-1 and TNFα levels remained 
constant in both wild type and MLCK knockout mice in all treatment groups (data not 
shown).   
 These data support the results observed following PIK treatment. Both inhibition 
and knockout of MLCK decrease intestinal morphological damage and inflammation 
following binge ethanol and burn injury. Furthermore, ZO-1 and occludin localization 
with actin is maintained in intestinal epithelial cells of MLCK knockout or PIK-treated 
wild type mice exposed to the combined insult. Overall, ethanol and burn-induced MLCK 
activation contributes to subsequent intestinal epithelial damage, bacterial translocation, 
and inflammation. Although knockout of MLCK did not reduce pMLC after the 
combined insult, other results suggest that it does have a role in intestinal barrier 
dysfunction and inflammation after binge ethanol and burn injury. 
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APPENDIX B 
DETAILED METHODS 
Burn Injury (+ethanol) Protocol: 
Materials: 
Hot plate 
Metal pan with lid 
Metal or plastic pan for control room temp water 
diH20 
Animal clippers with #40 surgical clip comb 
Thermometer 
1cc syringes with 27g needle 
3cc syringes with 25g needle 
0.9% normal saline (sterile) 
Burn injury template (check for proper size according to weight of mice) 
Paper towels 
Ketamine/Xylazine anesthesia (see solutions) 
20% ethanol (see solutions) 
Timer 
Procedure: 
Fill the pans with diH20 and turn the dial on the hotplate up to get the water heated while 
you administer alcohol, anesthetize the mice, etc.  The water needs to be heated and 
maintained at 92-95ºC.  At this point, the water will have some small bubbles in it on the 
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bottom of the pan, but will not be actually boiling.  It is important to use the thermometer 
and maintain this temperature for all of the burn-injured animals. 
1) Weigh mice in grams 
2) Inject mice (i.p.) with 150ul (or chosen dose volume) of either 0.9% sterile saline 
vehicle or 20% v/v ethanol solution (preparation indicated in Solutions), using a 
1cc syringe with a 27g needle. Allow 2-3 minutes between cages so there is time 
to shave and burn the mice at their scheduled time. 
3) Thirty (30) min. after saline/ethanol injection, anesthetize the mice by injecting 
the appropriate volume of Ketamine/Xylazine i.p. (preparation indicated in 
Solutions, refer to “Ketamine Xylazine” protocol for proper dosing of animals) 
4) As soon as they are asleep (approx. 5 min. after anesthesia injection), thoroughly 
shave the backs of the mice (Oster animal clippers with #40 comb). 
5) One at a time, place animals in appropriate burning template to give a 14-16% 
total body surface area scald injury according to their weight (see chart in 
procedure room), and proceed with the burn injury (or sham – dunking mice in 
room temp water). Make sure the shaved part of the back is “sealed” on the 
burning template by gently pressing the mouse down into the template. 
6) Hold the animal+template in the water for 7 seconds. Quickly blot the mouse’s 
back on paper towels. Removing as much hot water as possible from the animal 
prevents further scalding, and helps keep their body temp. up after burn.  Put the 
mouse back in a clean cage.  As soon as possible after the injury, resuscitate each 
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mouse with 1.0 ml of 0.9% sterile saline (i.p.), pre-warmed in 37C water bath, or 
on warming pads.   
7) Keep cages on heating pads for the next 3-4 hrs.to help the mice recover from 
procedure.  Mice can be returned to the mouse room once they are walking and 
fairly alert. 
8) Place some food pellets on the bottom of each cage; the mice can’t stretch their 
necks as easily to reach for food after burn injury.  Replace water bottles. 
Solutions: 
Ketamine/Xylazine: Diluted with 0.9% saline, 100 mg/kg ketamine, 10 mg/kg xylazine, 
70.0 uL/mouse i.p. (see Ketamine/Xylazine protocol for how to make)  
Ethanol:  
 20% solution is the final concentration, made from the 95% stock ethanol 
(marked for use in mice only). Dilute with 0.9% sterile saline.   
 Inject i.p., 150 uL for “low-dose” which will give a final BAC between 150-180 
g/dL. 
Notes: 
We perform our burn injury procedures between 7-10 am  
Anesthesia:  Initially, this protocol used Nembutal for anesthesia (through 2008).  
However, it is no longer available and JR modified the protocol in 2009 to switch to a 
ketamine/xylazine mixture, as previously used in the Faunce lab, but giving less than a 
burn only experiment or other procedure (70.0 uL instead of 100.0 uL for the average 20-
25g mouse) due to the combined effects of the anesthesia and ethanol.  JR ran several 
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pilot experiments to work out the optimal dosage.  Animals wake up faster and more alert 
from ketamine/xylazine than they did previously with Nembutal (i.e. wake up within an 
hour instead of several hours).  The different anesthesia protocol does not appear to affect 
parameters measured this far compared to historical data with Nembutal.
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Intestinal epithelial cell isolation protocol 
 (Keep samples on ice at all times, centrifuge runs done at 4C) 
- Open intestine lengthwise and wash with 4C CMF-HBSS (calcium and magnesium free), 
scrape away excess luminal contents/fecal matter 
- Transfer to 1.5 mL epi tube containing 10 mM DTT in CMF-HBSS [plus phosphatase 
inhibitor cocktail (PIC) tablet] and put on ice (samples should be in DTT solution for a 
minimum of 30 minutes either on ice or at 4C but can be in it longer if needed 
- Shake tube briefly and transfer tissue to 1.5 mL epi tube containing 1 mM EDTA in 
CMF-HBSS (plus PIC tablet) and leave at 4C or on ice for 1 hour. 
- After incubation, shake tube vigorously, remove and discard any large pieces of tissue 
- Run isolated cells (what’s left in the tube after removing large pieces of tissue) through a 
25g syringe several times to break up large chunks of cells.  Vortexing immediately prior 
to running through syringe helps prevent tissue clogging syringe needle. 
- Centrifuge samples at 1000g for 10 minutes 
- Discard supernate, add 100 uL cell lysis buffer to pelleted cells 
- Vortex samples for 30 seconds and then put on ice for 4 minutes 
- Centrifuge samples at 16000g for 15 minutes 
- Remove supernate (cell lysates) and place into another tube and aliquot as needed 
If desire to count cells before lysis, resuspend pellet in 100 uL cold PBS and count cells.  
Centrifuge again and remove supernate and then add cell lysis buffer to lyse cells. 
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Immunohistochemistry for Frozen Ileum  
Translated from Christian Gomez’s notes – 8-1-08, Jerry Turner (U Chicago) (AZ) 
Materials 
- Coplin jars 
- PAP pen 
- Rectangular Tupperware container 
- Paper towels 
- 1X PBS (1 L) 
- Normal Goat Serum (serum should be of same species as secondary Ab) 
- Primary Ab’s of choice 
- Secondary Ab’s (Fluorochrome or other of choice) 
- Mounting media 
- coverslips 
Protocol 
1. Defrost frozen slides for 20 minutes 
2. Mark with PAP pen 
3. Fix 30’ in 1% paraformaldehyde, 1mM CaCl2, PBS 
4. Wash 3 x 5’ in PBS 
5. Block 1 hr. in 5% Normal Goat Serum, Triton (0.3%), in PBS 
6. Tap off NGS, add primary Ab [diluted in Triton (0.3%) in PBS)], leave ON at 4C 
7. Wash 3 x 5’ in PBS 
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8. Incubate with secondary Ab (Alexa Fluor Ab’s are in 4C deli fridge, red box) 
[diluted in Triton (0.3%) in PBS)] for 1 hr. 
9. Wash 3 x 5’ in PBS (keep slides in dark during washes) 
10. Incubate with Phalloidin [1:100 for 30 min. (-20C) and Hoechst 1:20,000              
(-20C) for 2 min] if desired, wash 3 x 5 minutes between phalloidin and Hoechst 
11. Wash with tap water 
12. Air dry and coverslip 
- Never let slides dry except when defrosting and before coverslipping 
- Write down Lot, date opened of all Ab’s 
- Keep slides in dark place while doing PBS washes once add secondary Ab 
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Generic Western Blot Protocol (JK) 
Solutions to make (recipes at end of protocol): 
1L 5x Running Buffer (stock)   10% SDS (in dH20) 
1L 5x Transfer buffer (stock)    5M NaCl 
TEN, TBST, or PBST solution   0.5M EDTA 
3% milk in 0.05% Tween/PBS   1M Tris (pH 7.5) 
1L 1x Running buffer     1L 1x Transfer buffer 
Other solutions needed: 
-mercaptoethanol or DTT 
Sample Buffer (4x sample buffer Fisher Cat. #CB31010) 
Methanol 
Supplies needed: 
Electropheresis and transfer apparatus 
Gels (usually use BioRad Tris-HCl 4-20%, Cat # 456-1093) 
Filter Paper (BioRad Cat. #1703932) 
Foam/thin sponges 
Membrane (PVDF membrane: Millipore Cat #IPVH07850) 
Razor blade 
Gel loading tips (Fisher Cat# 02-707-138) 
1.5mL conical Eppendorf tubes (for samples, ladders) 
Western blot ladders (unstained: Biorad Cat # 161-0363, stained: Biorad Cat # 161-0324) 
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Electrophoresis 
- Protein assay on samples to determine amount of sample to use that equals 15 ug 
protein. (Use sample Western Blot 15 ug Excel file in protocols.  You can load higher 
amounts of protein if you choose.) 
- Turn on heating block (Rm 4228) and set temperature for 100F. (allow ~30 minutes for 
heating to set temperature) 
- Make 1x running buffer (from 5x) and prepare samples.  Remove protein ladders from 
freezer (-20) and place in ice bucket to defrost. Add ddH20, 2x (dilute 4X in dH20) 
sample buffer, and -mercaptoethanol to tubes according to amounts calculated in 
Western blot sample calculator.  Keep samples on ice at all times!  Add sample last and 
right before boiling! 
- Ladders prepared at following amounts –10uL ddH20, 25 uL Sample buffer, 5uL -
mercaptoethanol, 10uL ladder. 
- Once plate heater warms to temperature, place samples in heater and boil for 3-5 
minutes. Remove samples from heater and place back on ice immediately. 
- Gels are stored in 4C fridge.  To open, remove green tape along bottom.  Remove comb 
to expose wells.  Load gel(s) ensuring that green gasket ridge matches up with the gel.  If 
running only one gel, use buffer dam on other side.  Lock gels in place and load into 
electrophoresis dish – creates 2 outer and 1 inner reservoir. 
- Add 1x running buffer to inner reservoir first and check for leaks.  If none apparent, 
continue to add buffer to inner reservoir, allowing it to run over into outer reservoirs.  Fill 
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until wells are covered entirely by buffer, but do not go over top of gel/plastic.  
(Combining reservoirs will abolish the potential difference and nothing will happen) 
- Load wells with 20uL (depending on gel can load up to 30 uL) of sample using gel-
loading tips.  Be careful to not dispense any air bubbles into wells. 
- Put cap on dish – black to black, red to red.  Run gel at 103V for ~1 hour.  Check gel to 
make sure it is running.  Sample buffer (blue line) should be almost to bottom before 
stopping electrophoresis. 
Transferring to Membrane 
- Mark top of membrane with “Top” and initials, date, expt. # on bottom with pencil.  DO 
NOT TOUCH MEMBRANE!  
- Pour methanol into one small plastic dish.  Prepare 1L 1x Transfer buffer (recipe at end) 
and pour some (not all) into small plastic dish.  (one dish per transfer done, and one for 
removal of gel).  Place black portion of transfer holder into dish w/ buffer. Place sponge 
against pegs of holder, and place filter paper on top of sponge.  Remove air bubbles (roll 
test tube or pipette piece over filter paper).  
- To remove gel, crack open case (in dish with transfer buffer) with razor blade or 
spatula, gel will stick to one of the sides of the case.  Keep gel in transfer buffer and cut 
off wells using razor blade.  Slide gel onto filter paper; straighten and remove air bubbles.  
Remove membrane from methanol dish and rinse in ddH20 and then in transfer buffer. 
Using forceps, lay membrane (written side to gel) onto gel.  Move membrane around so 
as to cover entire gel and remove air bubbles.  Place another piece of filter paper over 
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membrane and remove air bubbles; place another sponge over filter paper and remove air 
bubbles.  Closer transfer holder and keep in transfer buffer until ready to load into 
transfer apparatus. 
- Wash electrophoresis equipment within minutes of finishing to prevent salt build-up 
which can affect equipement! (Wash with tap water, rinse with dH20) 
- Place transfer dish into rectangular ice container and surround dish with ice.  Place a stir 
bar at bottom of dish and put transfer holder (red and black) into dish.  Add ice container 
and your “transfer sandwich” (black part of transfer holder to black side of transfer 
apparatus) to dish.  Fill dish with transfer buffer (can use buffer used to make transfer 
sandwich).  Buffer should cover entire “sandwich”, but not overflow dish.   
- Place ice container on stir plate and put lid on dish - red to red, black to black.   
1 membrane – 200 mA for 1 hr. 
2 membranes – 350 mA for 1 hr. 
Blocking and Primary Ab 
- Carefully remove membrane from “transfer sandwich” and put into plastic dish 
containing TEN solution.   
- Wash transfer equipment within minutes of finishing to prevent build-up of salt 
affecting equipment! 
- Pour off TEN solution and add ~10-12 mL of 3% milk in 0.05% Tween/PBS.  Place on 
shaker at RT for 30 minutes - 1 hour. 
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- Add primary antibody to 10-12 mL milk solution.  Pour off milk solution and add 
primary antibody.  Cover with parafilm and place on shaker at 4C overnight. 
- (If primary antibody is phospho-specfic dilute antibody in 5% BSA in TBST solution) 
 
- Primary Ab’s usually used at 1:1000-1:5000 dilution, but check your individual 
antibody product sheet. 
Washing and Secondary Antibody 
- Pour off primary antibody into conical tube (Ab dilutions can be saved for ~1 week) and 
add 10-12 mL of TEN solution onto membrane.  Place on shaker for 10 minutes. Repeat 
2x for total of 3 washes. 
- Dilute secondary Ab in milk solution.  (Secondary Ab usually used at 1:2000-1:10,000 
dilution. Secondary Ab’s conjugated to HRP or other detection agent.  Unstained ladder 
requires StreptActin addition to secondary Ab dilution. (1uL StreptActin/5mL milk 
solution) 
-Pour off TEN solution; add secondary Ab.  Place on shaker at RT for 1 hour.  Wash 3x 
in TEN solution. (Secondary Ab dilutions can also be saved!) 
Detection (HRP) 
- Place piece of saran wrap on counter.  In 15 mL conical tube mix 1mL brown bottle, 
1mL clear bottle (Supersignal West Dura extended Duration Substrate- upstairs in 
common room) per membrane.  Place membrane (remove excess moisture by wiping 
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membrane against dish edges) on saran wrap.  Pour 2 mL detection reagent on 
membrane.  Using forceps pick up edges of membrane to ensure detection reagent gets to 
all portions of membrane.  Leave detection reagent on membrane for 2 minutes.  Pick up 
membrane and blot edges on paper towels to remove excess buffer.  Blot excess reagent 
from saran wrap as well.  Place membrane back on saran wrap and cover with saran 
wrap.  Keep saran wrap as flat as possible to prevent detection reagent sitting on one part 
of gel.  Fold edges of saran wrap to seal.   
- Use chapel to detect bands. (Chemi-Hi light) 
- After detection in chapel, remove membrane from saran wrap and put back into plastic 
dish containing TEN solution.  Wash 3x for 10 minutes each.   
- If wish to blot membrane with another primary antibody, add 10-12 mL of Stripping 
buffer to membrane and place in 37C incubator for 10-30 minutes.   
-Wash 3x for 10 minutes each in TEN solution.  After washes repeat procedure from 
blocking step. 
Recipes: 
5x Running Buffer (1L)  5x Transfer Buffer (1L)   
50mL 10% SDS   25 mL 10% SDS    
72g glycine    72g glycine    
15.15g Trizma Base   15.15g Trizma Base 
ddH20 to 1L    ddH20 to 1L 
10% SDS (1L)   5M NaCL (250mL) 
100g SDS    73.05g NaCl 
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1L ddH20    250 mL ddH20 
1x Transfer Buffer (1L)  3% milk/0.05%Tween-PBS 
600mL ddH20    3 g dry milk 
200mL 5x Transfer buffer  100 mL 0.05%Tween-PBS 
200mL Methanol 
Stripping Buffer (100mL)     TEN solution 
20 mL 10% SDS     1M Tris pH 7.5 (25ml) 
6.25 mL 1M Tris-HCl (pH 6.8)    0.5M EDTA pH 8.0 (2ml) 
72.95 mL ddH2O      5M NaCl (28ml or 56ml of 2.5M NaCl) 
0.8 mL -mercaptoethanol    ddH2O to 1L 
Other solutions possibly needed: 
10x TBS (1 L)     TBS-tween (TBST, 1L) 
24.2 g Trizma base    100 mL 10x TBS 
80 g NaCL     900 mL ddH2O 
pH to 7.6 (~20-30 ml HCL)    1 mL Tween 20 
fill to 1L with ddH2O     
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Glass slide homogenization for Lymph Nodes 
 
Supplies needed: 
- 1.5 mL Epi tubes 
- RPMI with 5% FBS 
- Frosted glass slides 
- Small petri dishes 
- Tryptic soy agar plates (large petri dishes) 
- Cell spreaders  (sterile or autoclaved) 
 
1. Collect lymph nodes in a 1.5 mL tube with 0.5 mL RPMI (without antibiotic and 
with 5% FBS), add RPMI sterilely to tubes on day of sac, keep on ice. 
2. Separate lymph nodes from connective tissue and transfer to a new 1.5 mL tube 
containing 0.5 mL RPMI.  (Lymph nodes should sink in RPMI.) 
3. Transfer nodes (cut tip from a 1 mL pipette tip to allow transfer of nodes and 
RPMI) to the frosted side of one glass slide.  Homogenize by crushing lymph 
nodes between the frosted sides of 2 glass slides over a small petri dish to collect 
the homogenate.  Wash slides with 200 uL of RPMI and transfer collected 
homogenate from small petri dish to 1.5 mL epi tube. 
4. Vortex homogenates. Pipette 100 uL of homogenate onto a Tryptic Soy Agar 
(TSA) plate.  Plate in triplicate. 
5. Leave plates overnight in 37C incubator.   
6. Count colonies at 24 hour.  
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